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ABSTRACT 
Background: 
HIV/TB co-infection causes high morbidity and mortality among people living with HIV and 
places immense burden to health systems in developing settings. Isoniazid Preventive 
Therapy (IPT) is recognised as one of the most effective means of reducing TB burden in 
PLHIV yet its implementation still remains suboptimal, especially in sub-Saharan Africa. IPT 
implementation in Kenya (a high HIV/TB burden country) remains sub-optimal and little is 
known about the factors that influence its implementation. Data is also limited on the 
acceptability of IPT among health care providers in this context. This study assessed the 
factors influencing the acceptability of IPT among health care providers in selected HIV 
clinics in Nairobi County, Kenya.  
Methods: 
The study employed a cross-sectional design with an exploratory sequential mixed methods 
approach whereby a qualitative study was conducted followed by a quantitative survey. It 
was conducted in the HIV clinics of three purposively selected public health facilities. 
Qualitative data were collected through in-depth interviews with 18 purposively selected 
health care providers while quantitative data was collected from all health care providers in 
the clinics (74). Qualitative data on factors influencing IPT acceptability were analysed 
thematically and guided the development of the quantitative tool.  An acceptability score was 
developed from nine items guided by four constructs of the Theoretical Framework for 
Acceptability. Explanatory variables were generated by grouping questionnaire items that 
assessed factors affecting acceptability. Multivariable linear regression analysis was 
performed to assess the relationship between the hypothesised factors and the acceptability 
scores. 
 
iv 
 
Results 
The qualitative inquiry found that policy and guideline-related, provider-related, patient-
related, intervention-related, structural and operational factors influenced the acceptability of 
IPT among health care providers. The overall mean acceptability score in the study 
population was 70.33% (SD: 12.79) which was categorized as moderate. The health care 
providers did not find the intervention fully comfortable, agreeable or satisfactory to use. 
Among the determinants of acceptability of IPT, patient-related: model coefficient 5.12 (95% 
CI -0.39 – 10.63; P=0.050) and intervention-related: model coefficient 6.72 (95% CI 3.42– 
10.01; P=0.000) factors were significantly associated with the acceptability scores in the 
quantitative analysis. An increase in the average composite score of these factors increased the 
acceptability score on average. Patient-related factors included patients’ adherence to IPT, pill burden, 
information on IPT, development of severe side-effects, refusal of IPT medication, clinical state and 
drug regimen. Intervention-related factors included INH resistance, side-effects and deaths, 
effectiveness of IPT, procedure of IPT related activities. 
Conclusion 
IPT was generally not fully acceptable among health care providers and was influenced by a 
number of different contextual factors. Among these, patient-related and intervention-related 
factors were important factors that affected the acceptability of IPT in the context of the three 
clinics. The promotion of evidence-based awareness and enforcement of implementation 
guidelines by policy makers and program managers are required to improve the acceptability 
of IPT among health care providers in the HIV clinics.  
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DEFINITION OF TERMS 
1. Acceptability: The perception among implementation stakeholders that a given 
treatment, service, practice or innovation is agreeable, palatable or satisfactory. 
 
2. Health Care Provider: This refers to clinicians, nurses, pharmacists, counsellors, 
peer educators, nutritionists and laboratory staff who are involved in providing care at 
the HIV clinics in the selected health facilities. 
 
3. Innovation: Newly introduced promotion and preventive approaches. This can also 
refer to a program or an intervention. For example, IPT. 
 
4. Isoniazid: Is an antibiotic used as a first-line agent for the prevention and treatment of 
both latent and active tuberculosis. It is also known as isonicotinylhydrazide. 
 
5. Quality implementation: Putting an innovation into practice in such a way that it 
meets the necessary standards to achieve the innovation’s desired outcomes.  
 
6. Frontline providers: These are health care providers who are involved in 
prescription and/or dispensation of IPT medication to the patients at the facilities. 
 
7. Non frontline providers: These are health care providers who are not directly 
involved in prescription and/or dispensation of IPT medication to the patients at the 
facilities but are involved in the IPT programme and provision of care to PLHIV. 
 
8. Innovation climate for implementation: The extent to which an organization values 
and rewards the evidence-based practice or innovation 
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CHAPTER ONE: INTRODUCTION 
1.0. INTRODUCTION OF CHAPTER 
This chapter gives background information and puts the study into context. The overall aim 
and objectives of the study are presented. In the literature review, the intervention IPT is 
introduced as well as the concept of acceptability as an implementation outcome. 
Furthermore, a review of the literature around the topic, pertinent issues and identified gaps 
are discussed. The chapter ends by presentation of the adapted conceptual framework used. 
1.1. BACKGROUND 
According to the World Health Organization (WHO) global tuberculosis report 2015, among 
the 9.6 million people infected with tuberculosis (TB) in 2014, 1.2 million were also co-
infected with human immunodeficiency virus (HIV) (1). People living with HIV (PLHIV) are 
about 20 to 30 times more likely to develop active TB compared to people without HIV. 
Moreover, TB is the leading cause of death among PLHIV, and in 2015, one in three deaths in 
PLHIV was attributed to tuberculosis (1). The HIV/TB co-infection burden is heaviest in 
Africa which accounts for 74% of cases globally (1). 
Kenya features on the WHO high burden country list for TB, HIV/TB co-infection and multi-
drug resistant tuberculosis (MDR-TB) (2). TB, the 4
th
 leading cause of death in Kenya, is a 
major cause of morbidity with approximately 90,000 cases notified in 2014, 9.2% of them 
being children. Nairobi County emerged with the highest number of cases at 13,917, 7.2% of 
them being children (3, 4). The Ministry of Health National TB, Leprosy and Lung Disease 
program (NTLD-Program) in their 2014 report indicated that TB deaths in PLHIV were 
increasing while deaths among those who are TB negative remained constant at around 4% 
(4). This is despite the global decline in mortality due to HIV associated TB (4). 
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To reduce the burden of TB among people living with HIV, the WHO recommends three 
interventions which are: intensified TB case-finding, isoniazid preventive therapy (IPT) and 
infection control for TB, collectively termed the three (3) Is for TB prevention (5, 6). These 
interventions are intended to be delivered in an integrated manner in both TB and HIV 
prevalent settings (6). The WHO encourages the integration of TB and HIV services and 
studies in sub-Saharan Africa have shown that integrated TB and HIV activities lead to 
improvements in TB treatment completion, improved case findings and reduced TB mortality 
(7, 8).  
Isoniazid preventive therapy is recognised as an important component of collaborative TB 
and HIV activities to reduce the burden of TB in PLHIV (6). IPT is the provision of isoniazid 
(INH) tablets by health care providers to PLHIV who are TB negative or have latent TB. The 
dose varies between 5mg/kg for children to 300 mg/kg for adults (9, 10). This preventive 
therapy is evidence-based with proven effectiveness of reducing the risk of TB in PLHIV by 
33-62% (11). The WHO 2011 guidelines for intensified tuberculosis case-finding and 
isoniazid preventive therapy for PLHIV in resource constrained settings strongly 
recommended at least 6 months of IPT for children and adults including pregnant women, 
PLHIV, those receiving anti-retroviral therapy (ART) and those who have successfully 
completed TB treatment (12). In areas of high prevalence and transmission of TB among 
PLHIV, IPT is conditionally recommended for a period of 36 months as a proxy for lifelong 
or continuous treatment (12).  
Kenya has adopted the collaborative TB/HIV services according to international and national 
guidelines and has been considered a leader in implementing recommended WHO TB/HIV 
collaborative activities (3, 4, 13). By 2014 IPT was being administered in select health 
facilities and was scaled up nationally in 2015 (3). However, limited information exists on the 
factors affecting IPT implementation from the local context (14).  
4 
 
Implementation research is a growing field that involves scientific inquiry into questions 
concerning implementation and attempts to solve a wide range of implementation problems 
(15). More often than not, evidence-based interventions fail to achieve desired health 
outcomes due to the implementation gap that exists between what is known and routine 
practice (16-19). Widespread evidence of suboptimal IPT implementation has been reported 
in low-income settings (6, 20, 21). Researchers have continually emphasized the importance 
of understanding and assessing the implementation of health care interventions at different 
stages of implementation to ensure quality and effective implementation (22-24). 
Consequently, different strategies, methods, theories, models and frameworks have been 
developed to ensure quality and effective implementation of evidence-based innovations.  
 Acceptability is one of the implementation outcomes used to assess how well 
implementation has occurred as well as provide insights on how this contributes to important 
health outcomes (15, 25). 
1.2. PROBLEM STATEMENT 
The Kenya NTLD-Program in 2014 reported limited use of IPT among PLHIV noting that 
though 83% were screened during their clinic visit, only 2% of those who tested negative 
were initiated on IPT (3). The latest survey of IPT coverage, indicated that only 29 924 
(3.6%) adults and 7 934 (10%) children eligible for IPT were initiated on IPT in 2015 (20). 
This indicates sub-optimal coverage, especially with regards to the National targets of 
initiating 90% of eligible population by the end of 2016 (20). HIV still remains the key driver 
of TB epidemic and National TB surveillance data indicates that HIV-infected TB patients 
are three times more likely to die compared to those who are TB negative (4). TB deaths in 
PLHIV have been increasing in Kenya despite a global decline in HIV associated TB deaths 
(3, 4). Coinfection with HIV and TB continues to be a major cause of morbidity and 
mortality in Kenya (20). However, there is a paucity of studies investigating reasons for the 
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suboptimal implementation of IPT. The few studies conducted on IPT implementation show 
limited use of guiding principles and frameworks of implementation research. Suboptimal 
implementation of IPT may be due to acceptability issues among the health care providers. 
To date, very little is known about the acceptability of IPT among health care providers in 
Kenya. Furthermore, present literature shows lack of consensus on the measurement of 
acceptability and offers little guidance on how to assess this outcome. 
1.3. JUSTIFICATION 
The outcomes of this study will shed light on the acceptability of IPT among health care 
providers in selected HIV clinics in Nairobi County and identify possible influencing factors 
in that context.   
The study findings will be useful to health care providers in the HIV settings and hospital 
administrators as its findings will highlight the quality of TB care offered to PLHIV and more 
specifically, the ‘quality’ of implementation of IPT in the facilities. This is because IPT is a 
key TB prevention strategy particularly in HIV management. Ultimately this will be crucial 
in improving the quality of care for PLHIV in this context. 
The findings of the study will additionally be of importance to the department of health at 
this early stage of IPT implementation as acceptability among health care providers serves as 
a proximal indicator of IPT administration as well as the quality and success of its 
implementation. It would encourage better monitoring and evaluation of the IPT program by 
program managers and policy makers. This will help in strategic planning to improve the 
administration of IPT among health care providers and their patients as well as tighten 
identified loop-holes that exist in its implementation.  
The study has the potential to be replicated to facilities in other counties and later national 
level to give a more generalizable picture of IPT implementation. This could in turn 
contribute to the achievement of the 2015-2018 National strategic objectives for TB control. 
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1.4. RESEARCH QUESTION, AIM AND OBJECTIVES 
RESEARCH QUESTION 
What factors influence the acceptability of IPT among health care providers in HIV clinics in 
Nairobi County, Kenya? 
AIM 
The overall aim of the study was to assess the factors influencing the acceptability of IPT 
among health care providers in selected HIV clinics in Nairobi County, Kenya.  
OBJECTIVES 
The study sought to address the following objectives:  
1. To understand factors affecting the acceptability of IPT (Isoniazid preventive therapy) 
among health care providers in selected HIV clinics in Nairobi County, Kenya. 
2. To measure acceptability of IPT (Isoniazid preventive therapy) among health care 
providers in selected HIV clinics in Nairobi County, Kenya. 
3. To examine the relationship between acceptability of IPT and identified determinants 
in selected HIV clinics in Nairobi County, Kenya.   
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1.5. LITERATURE REVIEW 
1.5.1. The dual burden of HIV and TB 
As resource-limited countries rapidly expand their HIV/AIDS treatment and care 
programmes, co-infection with TB and HIV has become a major public health threat for 
PLHIV and the society at large (11). TB is the most common opportunistic infection in HIV-
infected patients in resource-limited settings and is associated with high mortality in patients 
commencing antiretroviral combination therapy (ART) (26). Co-infection with HIV and TB 
also places immense burden to health systems in developing settings and threatens efforts 
aimed at achieving globally set targets (27, 28). Kenya is among the world countries that 
account for 97% of the estimated global number of TB cases each year among PLHIV (2). 
According to the NTLD-Program, considerable progress has been made to reduce the 
HIV/TB co-infection rate in Kenya from 45% in 2008 to 33% in 2015 (20). Though higher 
than the 12% global co-infection rate, it is lower than the African region co-infection rate of 
39%. In 2015, approximately 25,030 (31%) of the 81,518 persons who developed TB in 
Kenya were HIV infected (20). Despite the mentioned continuing efforts, TB/HIV co-
infection continues to be a major cause of morbidity and mortality in Kenya. The case fatality 
among notified HIV/TB co-infected patients increased from 10% in 2013 to 11% in 2014 
(20). 
1.5.2. Interventions to reduce HIV/TB co-infection burden 
To decrease the joint burden of HIV and TB, the WHO in its 2004 interim policy report 
recommended collaborative activities intended for decision-makers, TB and HIV/AIDS 
programme managers, donors, development agencies, and non-governmental organizations 
involved in TB and HIV/AIDS programmes (5). To reduce the burden of TB in PLHIV, the 
policy recommended the establishment of intensified TB case-finding, introduction of IPT, 
and ensuring TB infection control in healthcare and congregate settings (5). The policy also 
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recommended interventions to reduce the burden of HIV in TB patients which included: 
providing HIV testing and counselling, introduce HIV prevention methods, introduce co-
trimoxazole preventive therapy, ensure HIV/AIDS care and support, and introduce 
antiretroviral therapy (5).  
In 2012, an update of the 2004 policy on collaborative TB/HIV activities was published 
which recommended ART in addition to interventions proposed to reduce TB burden in 
PLHIV (6). International guidelines for monitoring and evaluation of collaborative TB/HIV 
activities have been published to assist in the implementation collaborative TB/HIV activities 
(29). To date, many countries have adopted the collaborative TB/HIV activities 
recommended by the WHO. However, the level of implementation and integration of TB and 
HIV/AIDS activities at the service delivery points vary from country to country and among 
different settings within the countries (30). 
1.5.3. Isoniazid Preventive Therapy 
IPT, part of the three I’s for HIV/TB, is recognised as an important component of 
collaborative TB and HIV activities to reduce the burden of TB in PLHIV (6). It is 
recommended for provision to individuals with documented latent infection with 
Mycobacterium tuberculosis to prevent progression to active disease, and for PLHIV living in 
areas with high HIV prevalence and latent TB prevalence greater than 30% (5, 6, 11). IPT 
involves the provision of isoniazid (INH) tablets by health care providers to PLHIV who are 
TB negative or have latent TB. The dose varies between 5mg/kg for children to 300 mg/kg 
for adults (9, 10).  
IPT has been proven from research to reduce the risk of TB in PLHIV at individual, 
community and population level (11). More evidence has also been generated indicating the 
effectiveness of combined use of IPT and ART in significantly reducing TB incidence among 
PLHIV (31, 32). Moreover, IPT was found to be cost effective in studies conducted in 
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settings with high TB and HIV prevalence (33-35). The WHO 2011 guidelines for IPT in 
resource constrained settings strongly recommended at least 6 months of IPT for children and 
adults including pregnant women, PLHIV, those receiving anti-retroviral therapy (ART) and 
those who have successfully completed TB treatment (12). In areas of high prevalence and 
transmission of TB among PLHIV, IPT is conditionally recommended for a period of 36 
months as a proxy for lifelong or continuous treatment, whether or not ART is being received 
(6, 9) .  
Eligibility for IPT includes the absence of active TB confirmed by the health care provider 
using a simplified screening algorithm as well as presence of latent TB. The screening 
algorithm involves absence of one of the symptoms of current cough, fever, weight loss or 
night sweats (6). Latent TB is identified through the tuberculin skin test (TST) and a positive 
result indicates presence of latent TB infection. Though PLHIV benefit more from ART, it is 
not a requirement for initiating IPT in PLHIV (5, 6). 
1.5.4. Implementation of IPT 
With improved monitoring of the scale-up of the HIV/TB collaborative activities since 
inception in 2003, considerable progress has been made in their implementation. For 
instance, the screening of TB among HIV-positive people and IPT provision more than 
doubled between 2007 and 2009 with the total number screened increasing from 0.6 million 
to 1.7 million globally (36).  80 000 eligible PLHIV were initiated on IPT in 2009; an 
increase from 30 000 people initiated in 2007. However, the figure only represented 1% of 
PLHIV worldwide (36). 933 000 PLHIV were initiated on IPT in 2014, which was an 
increase from just over 600 000 people reported in 2013 (1). The number of PLHIV initiated 
on TB preventive therapy in 2015 was 910 124, similar to the 2014 estimates (21). The data 
indicate great strides from the coverage levels in the early 2000s. 
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Since the recommendation of international guidelines on the three I’s for TB/ HIV, adoption 
and implementation of IPT has been largely varied and relatively slow, especially in high 
burden TB countries (1, 10, 21, 37-40). Kenya has adopted and is implementing the 
recommended international and national guidelines for collaborative TB/HIV activities (6, 
13, 20). IPT implementation for PLHIV in Kenya begun in 2012 through PEPFAR 
implementing partners such as AMREF, USAID and AMPATH, among others. The 
programme was rolled out in predetermined pilot treatment facilities across the country which 
gave the basis of development of health systems to ensure IPT is optimally provided (41).  
Country-wide implementation of IPT was launched in March 2015, beginning with Siaya, 
Kisumu, Migori, Homa-bay and Nairobi as the pioneer counties due to their high HIV disease 
burden. Other counties followed suit from September 2015 (20, 41). It’s roll-out was 
complemented with an ambitious target of enrolling 90% of PLHIV (839 797 adults and 79 
594 children) on IPT by December, 2016 (20). The latest survey of IPT coverage, indicated 
that only 29 924 (3.6%) adults and 7 934 (10%) children eligible were initiated on IPT in 
2015 (20). The WHO Global TB report indicated that, in 2015, only 33% of people newly 
enrolled in care were initiated on IPT in Kenya. In the same year, only 5.5% of children 
under 5 years were initiated on IPT in Kenya (21). As such, the implementation of IPT has 
been considered sub-optimal and still lagging behind with regards to the aforementioned 
national targets (20).  
1.5.5. Implementation Outcomes 
Implementation research is the scientific inquiry into questions concerning implementation 
(15). Evidence has consistently indicated that effective implementation is associated with 
better program outcomes (22, 23). Further implementation literature has been presented in 
Appendix F of this report. To understand the implementation process, implementation 
research utilises outcome variables. They have been defined as the effects of deliberate and 
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purposive actions to implement new treatments, practices and services (25). They assess how 
well implementation has occurred (15). In addition, they serve as indicators of 
implementation success, proximal indicators of implementation processes and are key 
intermediate outcomes to service or program outcomes (25, 42).  
A conceptual model for implementation research was established by Proctor and colleagues 
in 2009, later updated in 2011 to describe a taxonomy of eight implementation outcomes:  
acceptability, feasibility, adoption (uptake), penetration, cost, fidelity, appropriateness and 
sustainability (25, 43). This study will focus on acceptability, with regards to IPT 
implementation in HIV/TB integrated services.  
Acceptability has been defined as the perception among implementation stakeholders that a 
given treatment, service, practice or innovation is agreeable, palatable or satisfactory (25). It 
can be measured both from the perspective of the provider as well as the consumer, and at 
different stages of implementation vis early during the implementation process, during 
ongoing implementation of the intervention and later in the implementation process for 
sustainability (25). Researchers have used quantitative methods as well as qualitative 
methods to measure the acceptability of interventions in health. Some of the methods have 
been discussed in section 1.5.7. 
1.5.6. Factors affecting the implementation of IPT 
Stemming from reports of sub-optimal coverage and implementation of the intervention over 
the years, studies are increasingly being conducted to identify factors influencing the 
implementation of IPT. Though limited, studies have been conducted in low and middle-
income settings most burdened by HIV and TB coinfection. They have been conducted in 
health care settings, among health care providers, patients or both, among policy makers and 
health systems to elucidate factors responsible for the sub-optimal IPT implementation.  
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A qualitative study conducted among health care providers in Ethiopia found that patient 
level factors including poor adherence; lack of understanding and patient non-disclosure of 
HIV sero-status; underlying mental health issues; weak patient-provider relationship; lack of 
patient information, patient empowerment and proper counselling on IPT; and the deficient 
reinforcement by health officials and other stakeholders affected the implementation of IPT 
in that context (38). A similar study in Ethiopia among health care providers found isoniazid 
stock-out, fear of isoniazid resistance, problems with patient acceptance and lack of 
commitment by health managers to scale up the program as the major factors hindering IPT 
implementation (10). In a South-African qualitative study, lack of knowledge and experience 
on IPT by health care providers was a major barrier to IPT implementation in addition to 
operational and patient-derived barriers (37). Consistent with other studies, fear of isoniazid 
resistance was cited as a perceived operational barrier in addition to poor integration of 
services and uncertainty of eligibility tests before IPT delivery. Patient-derived barriers 
included poor adherence, pill burden, poor information and socioeconomic problems (37). 
Studies have also been conducted on barriers to policy level implementation of IPT in high 
HIV and TB burden countries. A study on national implementation of co-trimoxazole 
prophylaxis (CTXp) and IPT among policy managers reported inadequate ICF because of the 
inability to exclude active TB, logistic difficulties to exclude tuberculin skin test to diagnose 
latent TB infection, inadequate patient adherence causing isoniazid mono-resistance and lack 
of consensus among policy makers and uncertainty regarding the long-term benefits of IPT 
(44). A 2009 study assessed public health challenges and IPT implementation barriers. 
Perceived barriers included uncertainty on responsibility for IPT implementation among 
stakeholders; operational challenges in identification of latent TB; difficulties in excluding 
active TB and preventing isoniazid resistance, treatment of latent TB infection and duration 
of protective efficacy (45). Health system factors have also been largely found to affect IPT 
13 
 
implementation (46, 47). Leadership and governance, service-delivery, supplies and products, 
health workforce, health information system and health-system financing were broad health-
system factors that affected the implementation and nationwide scale-up of IPT (46). 
Availability of health care facilities and health personnel have been reported as health system 
barriers affecting IPT implementation (47).  
1.5.7. Acceptability of IPT  
In their development of measures of acceptability, feasibility and appropriateness, Care and 
colleagues viewed acceptability in terms of innovation-individual (provider) fit (48). A 
limited number studies have assessed acceptability of IPT in low resource settings. However, 
in the few studies that have been conducted on IPT implementation, perception or attitude 
towards IPT by both the health care practitioners and patients has been found to be an 
important influencing factor, among others, on its implementation. For instance, a qualitative 
study conducted in South Africa found that a change in health worker perception  was needed 
to improve IPT uptake in addition to overcoming operational barriers (37). In addition to drug 
stock-out, fear of isoniazid resistance and lack of commitment to scale up, problems in 
patients acceptance emerged as barriers to IPT implementation in a study conducted in 
Ethiopia (10). A study on the acceptability and adherence of IPT among HIV-infected 
patients in Tanzania found IPT to be highly accepted by HIV-infected patients with high level 
of adherence which contributed to improved IPT uptake (49). 
Other studies conducted in different contexts have assessed the acceptability of other health 
interventions at different stages of implementation. Some have been conducted in well-
resourced or high income settings while others have been conducted in low-resourced 
settings. A 2015 study by Dingwall and colleagues assessed the acceptability, feasibility and 
appropriateness of a new e-Mental health resource for service providers using qualitative 
methods. Visual appeal, ease of use, cultural relevance and innovative format emerged as 
14 
 
contributing factors to the acceptability levels (50). Another study in China assessed the 
acceptability and adoption of handheld computer data collection (HCDC) for public health 
research at initial implementation. They found that the innovation was feasible, acceptable 
and preferred among the interviewers (51).  
Studies have also measured acceptability of health interventions among consumers. For 
instance, a study in Uganda on the acceptability, feasibility and use of malaria rapid 
diagnostic tests (mRDTs) at peripheral health facilities defined acceptability as “positive 
perceptions, beliefs and attitudes towards mRDTs and test results among users”. Their study 
utilized an adapted conceptual framework for acceptance and found a variety of factors that 
affected the acceptability and adoption of RDTs among health workers. Some of the factors 
included the design and characteristics, availability and quality of mRDT supplies, health 
worker capacity, availability of effective malaria treatments, reliability of the supply chain, 
existing national policy recommendations, individual health worker dynamism, and vitality of 
supervision (52).  
Different researchers have adopted context-specific instruments that were used to measure 
the acceptability or attitude towards different interventions in health care. For instance, 
Aaron’s 2004, used an 18 item questionnaire containing four dimensions to measure mental 
health providers’ attitudes towards the adoption of evidence-based practice (53). Similarly, 
Karlsson and Bendsten 2005 used a 12-item questionnaire to measure patients’ acceptance of 
computerized alcohol screening in an emergency department (54). Acceptability of clinical 
decision rules in a paediatric emergency department utilized an adapted 12-item 
questionnaire, the Ottawa acceptability of decision rules instrument. The twelve items were 
categorized into three categories (55).  
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1.5.8. Conceptual framework for factors affecting acceptability 
Using a review of empirical literature by and Durlak and Dupre (56), a synthesis of existing 
theories and frameworks by Damshroder et al. (57) into the CFIR (Consolidated framework 
for implementation research) and Chaudoir et al. 2013 (58) multilevel framework of factors 
that impact implementation outcomes, the study adapted a conceptual model that groups 
factors affecting acceptability under five main categories: Organizational factors, patient-
level factors, provider level factors, structural factors and innovation characteristics. 
Reviewed literature on factors affecting the implementation of IPT from low resource settings 
guided the items grouped under each category.  
A multi-construct theoretical framework of acceptability of health care interventions was 
developed by Sekhon et al. 2017, known as the theoretical framework for acceptability 
(TFA). This framework can be applied to assess both prospective and retrospective 
acceptability from the perspective of both intervention providers and recipients (59). The 
framework has got seven component constructs that can be used to measure acceptability of 
health interventions. For our study, four applicable component constructs were used to 
measure the acceptability of IPT among the health care providers. These are: affective 
attitude, intervention coherence, perceived effectiveness and self-efficacy. The conceptual 
model for factors affecting acceptability of IPT is shown in Figure 1.1: 
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Figure 1.1 Conceptual model of factors affecting Acceptability of IPT among health care providers. 
Adopted from Chaudoir et al., 2013(58), Durlak and Dupre, 2008(56) and Damshroder et 
al.2009(57).      ------ = Not operationalised 
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CHAPTER 2: METHODOLOGY 
2.0. INTRODUCTION 
This chapter gives details on the methods involved in the study. Key aspects of the study such 
as the design, study setting, sampling strategy and participant selection, data collection and 
management are described. Variables used in the study as well as their analysis methods are 
presented. In addition, ethical considerations are outlined.  
2.1. STUDY DESIGN 
This was a cross-sectional study which employed a mixed-methods approach. Mixed methods 
enables a better understanding of the research problem (60). An exploratory sequential 
mixed-methods approach was employed which began with the collection of qualitative data 
to explore contextual factors affecting the acceptability of IPT and used the obtained 
information to inform the quantitative phase of the study (61). In this case, the obtained 
qualitative information collected was analysed and used to inform the development of the 
questionnaire for the quantitative enquiry. 
2.1.  STUDY SITE 
Data were collected from health care providers working in the HIV clinics, also known as 
comprehensive care centres (CCC) of three public health facilities in Nairobi County, Kenya. 
Nairobi County is located in the central part of Kenya with an area of 694.9 km
2
 and a 
population of about 3,138,369 people (62). The three health care facilities were purposefully 
selected based on their physical location, size of the facilities, high volumes of HIV and TB 
patients who access integrated treatment services. Additionally, Nairobi County was one of 
the pioneer counties for the national roll-out of IPT in 2015 and hence it was expected that 
the health facilities would be implementing the intervention. Additional description of the 
three study sites is as follows: 
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Kenyatta National Hospital 
This is a national teaching and referral hospital in Kenya located in Nairobi County.  It has a 
bed capacity of 1800 and over 6000 staff. The CCC in the facility houses about 45 health 
personnel of different cadres namely: clinical officers, nurses, counsellors, pharmacists, 
medical officers, nutritionists, clinical psychologists, peer educators and social workers. The 
total number of patients in HIV care was 10,226 during the stud period. IPT uptake in the last 
quarter of 2016 stood at 5,733. An average of 1,974 patients visited the clinic per month in 
the last quarter of 2016. 
Mbagathi District Hospital 
Mbagathi Hospital is a County referral hospital located on the outskirts of the Kibera 
informal settlement in Nairobi County. The CCC in the hospital began in 2005 with the aid of 
the Government of Kenya (GOK) and Médecins Sans Frontières (MSF). The CCC has got 
about 25 health care workers of different cadres namely: clinical officers, nurses, counsellors, 
pharmacists, medical officers, nutritionists, peer educators and social workers. The total 
number of patients in HIV care was 4,860 during the study period. IPT uptake in the last 
quarter of 2016 stood at 839 patients. 400-500 patients visit the clinic weekly on average. 
Mama Lucy Kibaki Hospital 
This is a sub-county hospital located in Embakasi West Constituency in Nairobi County. This 
hospital has a bed capacity of 112 and serves a population close to 187,020 patients. The 
CCC of the health facility, which started in January 2016, houses about 25 health care 
providers. Clinical officers, nurses and pharmacists constitute a small percentage of the 
providers while other cadres (nutritionists, counsellors, peer educators and community health 
care workers) constitute the bulk of the health care providers. A total of 1,133 patients were 
enrolled in care at the time of study, 205 of them being initiated on IPT. An average of 100 to 
200 patients visit the centre per week.  
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2.2. STUDY POPULATION 
Respondents were selected from health care providers (clinicians, nurses, pharmacists, 
counsellors, peer educators, nutritionists, clinical psychologists and laboratory staff) working 
in the HIV clinics of the selected health facilities within Nairobi County, Kenya between 
January and June, 2017. Frontline providers (clinicians, nurses, pharmacists) are involved in 
prescription and/or dispensation of IPT medication to the patients at the facilities. Non-
frontline providers (counsellors, peer educators, nutritionists, clinical psychologists and 
laboratory staff) are not directly involved in prescription and/or dispensation of IPT 
medication to the patients at the facilities but are involved in the IPT programme and 
provision of care to PLHIV i.e. provision of information regarding IPT, identification of 
emotional, mental, behavioural and nutritional problems  and provision of support with 
regards to IPT as well as ascertainment of clinical eligibility for IPT.  
2.3. SAMPLING PROCEDURES 
2.3.1. QUALITATIVE 
Eighteen health care providers, from the three health facilities, were purposefully selected 
and participated in the in-depth interviews. They were selected based on their sex, cadre and 
length of stay at the HIV clinic. 
2.3.2. QUANTITATIVE 
All health care providers in the HIV clinics of the facilities were included in the study. Ninety 
five healthcare providers were reported to be working in the 3 health facilities at the time of 
study. Since the total study population size for the CCC in the three health care facilities was 
small, and the study being largely exploratory, the survey was conducted with all the health 
care providers in the clinic in order to quantify their acceptability of IPT in HIV care in the 
facilities (61). A total of 74 health care providers out of 95 provided informed consent and 
participated in the survey.  
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Calculated Power of the study 
Using the study sample of 95 health care providers, a power of 95.94% was obtained at the 
5% level of significance. The parameters are as below: 
Acceptability level obtained in the study = 0.7034; estimated acceptability level in population 
(null)=0.5; precision=0.2 
2.4. DATA COLLECTION 
2.4.1. QUALITATIVE 
In-depth interviews were conducted using a developed interview guide (See Appendix C). 
Open, non-directed questions were asked to elucidate perceptions about IPT and factors 
influencing the acceptance of IPT in the HIV clinics. The interviews were conducted by the 
researcher at the health facilities in English language, in private and at the convenience of the 
participant. They were about 45 minutes long and were audio-recorded. 
2.4.2. QUANTITATIVE 
Quantitative data on the acceptability of IPT services for PLHIV were collected from the 
health care providers using a questionnaire which was developed based on the qualitative 
findings (See Appendix E). The questionnaire was administered to the participants by the 
researcher and trained field-assistants at the HIV clinics in the selected health facilities. 
Variables were measured on a 5 point scale (Strongly agree, agree, neither agree nor disagree, 
disagree and strongly disagree) to obtain the level of acceptability of IPT and influencing 
factors among the health care providers. Both the qualitative interview guide and 
questionnaires were pilot tested at an HIV clinic of a different health facility within Nairobi 
County. The data were collected between February and April, 2017. The data collection tools 
are in Appendices C and E.  
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2.5. DATA MANAGEMENT 
2.5.1. QUALITATIVE 
Qualitative data were transcribed verbatim. Data verification for accuracy and completeness 
was done through reading and re-reading of the interview transcripts by the principal 
investigator and one research assistant to ensure all the recorded information and variations 
were identified. The soft copies of the interview transcripts were stored in a password 
protected computer while hard copies were filed and stored in a lockable cabinet. 
2.5.2. QUANTITATIVE 
Quantitative data were collected using paper questionnaires and captured using REDCap 
(Research Electronic Data Capture) software and stored on assigned secured Wits Institution 
database. The completed questionnaires were edited by the researcher and a research assistant 
to ensure completeness and accuracy during data entry into the electronic database. Some of 
the data cleaning activities performed on the REDCap platform included screening of the 
captured data for missing values and inconsistencies. The data were exported to Microsoft 
Excel software as a spreadsheet file and subsequently to Stata Version 14.0 as a data file for 
statistical analysis.  
The outcome variable, acceptability was measured using a composite score created from nine 
items that assessed acceptability over four constructs of the Theoretical Framework for 
Acceptability. Acceptability was defined in this study as the perception among health care 
providers that IPT is agreeable, comfortable and satisfactory.  
Variables were recoded from continuous to categorical for data analysis. This included 
participants’ age which was recoded into three categories (less than 30 years, 31-40 years and 
above 40 years). Job-category of the participants was recoded from nine categories into two 
categories: frontline providers (clinical officers, nurses, pharmacists) and non-frontline 
providers (counsellors, peer educators, medical social workers, nutritionists, clinical 
pychologists and laboratory scientists) to facilitate analysis.  
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A score was generated for the determinants of acceptability by calculating the mean of 
questionnaire items that measured that item. Highest score was 5 while lowest score was 1. A 
higher score indicates positive perception to IPT with regards to the determinant i.e. 
Agreement with a positive statement or disagreement with a negative statement assessing a 
construct. A lower score indicates negative perception with regards to the determinant i.e. 
disagreement with a positive statement of agreement with a negative statement assessing a 
construct. 
2.6. VARIABLES AND THEIR DEFINITIONS 
Outcome Variable: Acceptability 
According to the Implementation Outcome Framework (IOF) by Proctor et al. 2011, 
acceptability is defined as the perception among implementation stakeholders that a given 
treatment, service, practice or innovation is agreeable, palatable or satisfactory. 
Explanatory variables:  
These comprised factors that influence acceptability of IPT identified from the in-depth 
interviews. They included provider-related, policy/ guideline-related, intervention-related, 
operational, structural factors and patient-related factors which were generated from grouping 
of questionnaire items into the different constructs (as explained in section 2.5). Demographic 
characteristics of health care providers (Age, sex, job category, and years of experience in 
providing HIV/TB care) were also included.  
2.7. DATA ANALYSIS 
Qualitative analysis 
Objective 1: To understand factors affecting the acceptability of IPT among health care 
providers. 
The data collected from in-depth interviews was analysed through inductive thematic 
analysis. Coding of the transcripts was done to identify key words, messages, and patterns. 
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The developed codes were matched to ensure integrity and similarity between the 
researchers. A code book was then developed after integration and collation of the identified 
codes. From the codebook, broader themes and sub-themes that emerged from the data were 
identified and reviewed to ensure they were appropriate for the interpretation (63). A refined 
conceptual model (see Figure 2.1) was then developed from the identified themes that guided 
the questionnaire development for the quantitative enquiry. There was much similarity in the 
constructs between the refined and the original conceptual model. Policy and guideline-
related factors were added as a construct while organizational factors did not feature in the 
modified framework. 
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Figure 2.1 Refined conceptual model for factors influencing the acceptability of IPT among 
health care providers in selected HIV clinics in Nairobi County, Kenya 
------ = Not operationalised 
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Quantitative data analysis 
Objective 2: To measure acceptability of IPT (Isoniazid preventive therapy) among health 
care providers. 
Acceptability was measured using a composite score created from nine items that assessed 
acceptability over the four constructs of: affective attitude, intervention coherence, perceived 
effectiveness and self-efficacy. The internal consistencies of the items were computed and 
guided the decision to sum up the score for each respondent. The acceptability score was 
converted to percentages and described using tertiles categorized as follows: 
High acceptability: acceptability score between 80 and 93 (tertile 3) 
Moderate acceptability: acceptability score between 64 and 78 (tertile 2) 
Low acceptability: Acceptability score between 44 and 62 (tertile 1) 
Box plots were used to graphically present the acceptability scores. Tables were used to 
summarise the acceptability scores and distribution by different characteristics in the study 
population. Means and standard deviations as well as medians and IQR of the acceptability 
scores were reported.  
Objective 3: To examine the relationship between acceptability of IPT and identified 
determinants. 
The factors influencing acceptability were presented in frequency distribution tables to show 
the distribution of the likert responses across the different categories. The Chronbach’s alpha 
values for internal consistency were reported for constructs created using questionnaire items 
that investigated different factors influencing acceptability of IPT (See Table 3.5). 
General linear models were fitted to examine the relationship between acceptability scores 
and the determinants. Unadjusted linear regression analysis was conducted to test for 
independent association between acceptability scores and each of the explanatory variables. 
An adjusted linear regression model was fitted with all the explanatory variables included. 
Variables that were non-significant in the unadjusted model were still included in the 
adjusted model since they had already been found to be factors influencing IPT acceptability 
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from the qualitative inquiry. The regression coefficients and the 95% confidence intervals 
were reported for each of the models.  
Qualitative and quantitative findings were mixed in the discussion section (Chapter 4). 
2.8.  LIMITATIONS OF THE DATA 
The quantitative portion of the study had a small sample size (74 participants). This may have 
limited the ability to detect an existing effect.   
2.9. ETHICAL CONSIDERATIONS 
tudy approval and ethical clearance to conduct the research was obtained from the Wits 
Human Research Ethics Committee (HREC) (approval No. M161164), The Kenyatta 
National Hospital-University of Nairobi Ethics and Research Committee (approval No. 
P11/01/2017) and the Kenya Medical Research institute Ethics and Research Committee 
(approval No. RES/7/3/1) (See Appendix G-I).  A research permit was obtained from the 
National Commission for Science, Technology and Innovation (NACOSTI) to conduct the 
study in Nairobi County, Kenya (See Appendix F). Permission to access the selected health 
facilities was obtained from the management of the respective health facilities. 
Information about the study was provided to the study participants through a detailed 
information sheet. Voluntary, written informed consent was obtained from all the participants 
before their participation in the study. Participation in the study was voluntary and 
participants were free to withdraw at any time during the session without any recourse. The 
provided information from study participants was anonymized during analysis and reporting. 
For the qualitative reporting, only the facility information was reported against quotations. 
After data collection, the interview audio recordings and survey electronic responses were 
stored in a password protected computer and will not be used for any other research related 
activities. They will be completely deleted from the system six and ten years respectively 
after storage. 
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CHAPTER 3: RESULTS 
3.0. INTRODUCTION 
This chapter presents the results from both the qualitative and quantitative enquiry.  
Quotations are presented to illustrate the emergent themes from the qualitative inquiry. 
Quantitative results are presented in tables and graphs. 
3.1. Factors affecting the acceptability of IPT (Qualitative results) 
Eighteen health care providers from the CCC of the selected health care facilities participated 
in the in-depth interviews. Their demographic characteristics are presented in Table 3.1. 
Their median age was 36 (32 - 40) years. The sample comprised of eight clinical officers, 
four nurses, four counsellors and two pharmacists. A majority of the participants (78%) had 
more than four years’ experience in providing HIV/TB care. After thematic analysis of the 
qualitative data, six broad themes were elucidated. These included: factors related to IPT 
policy and guidelines, patient-related factors, provider-related factors, intervention-related 
factors, structural and operational factors. The emergent themes and their interrelationships 
are presented in the following sections.  
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Table 3.1: Demographic characteristics of health care providers who participated in in-
depth interviews at selected HIV clinics in Nairobi County, Kenya 
Variable 
 
Value Frequency 
(n) 
Percentage  
(%) 
Sex Males 7 31 
 Females 11  61 
    
Job category Clinical officers 8  45 
 Nurses 4  22 
 Counsellors 4  22 
 Pharmacists 2  11 
    
Years of Experience in 
HIV/TB care (years) 
< 1 2  11 
2 – 4 2  11 
 > 4 14  78 
    
Age (years) ≤ 30 4 22 
 31 – 40 10  56 
 41 – 50 1  5 
 > 50 3  17 
3.1.1. Policy, guidelines and standard operating procedures (SOPs)  
Factors related to policy makers and program managers as well as IPT guidelines and SOPs 
in the HIV clinics were found to affect the acceptability of IPT among the health care 
providers.  
Discomfort with IPT guidelines and SOPs 
The participants indicated that the guidelines followed for IPT in the clinics were those 
implemented at National level by the NTLD-Program and NASCOP, guided by the WHO 
international guidelines. However, health care providers expressed discomfort with the 
guidelines and SOPs citing lack of clarity, which affected their perception and delivery of the 
intervention. The health care providers proposed revision of the guidelines on IPT with 
specific regard to eligibility criteria and clarity on ruling out active TB and latent TB before 
prescription, duration of IPT and national consensus on IPT-related services as part of the 
HIV/TB collaborative activities, since some of the services differed among facilities.  
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“I think it’s a good idea but the problem is with the protocol. Yeah! the SOPs. They 
are not well...they are not very clear. They are not well documented...”(health care 
provider, KNH) 
“…Because sometimes you find there are some areas that give IPT, that is isoniazid 
and pyridoxine. Some don’t give isoniazid and pyridoxine…So you wonder whether it 
is the SOP or is it something that centre has come up with?...” (health care provider, 
KNH) 
Limited staff involvement in IPT guideline implementation 
The participants also indicated that there was pressure from policy makers to implement the 
proposed IPT policy guidelines at introduction and revision without provider involvement. 
This made them to prescribe the intervention without actually being comfortable with its 
delivery. 
“...They assume you know all that…But if you ask someone, “Why are you doing re-
treatment for six months?” They don’t know why. It’s just you are pushed to do things 
but you’re not empowered with so much knowledge to understand why you are doing 
it.”(health care provider, Mama Lucy Kibaki Hospital) 
Inadequate policy makers’ commitments to IPT implementation 
Another factor cited by the health care providers was the limited commitment by the policy 
makers and IPT program managers in ensuring the effective implementation and streamlining 
of the IPT program, which consequently demotivates the health care providers. 
“…there is no initiative by those who are concerned in the TB program. They need  to 
make sure that they insist on IPT, and put some regulations or some rules to be 
followed to ensure IPT is given to every eligible patient…”(Health care provider, 
KNH) 
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3.1.2. Intervention-related factors 
Factors related to IPT itself were also found to affect the participants’ comfort or satisfaction 
with the intervention. These factors were related to guidelines, provider and patient factors.  
Perceived effects of IPT 
Fear of drug resistance emerged as a major factor that affected their perception of IPT and 
consequently, delivery. They expressed concern over the development of MDR or XDR-TB 
in patients who had been previously on TB medication or developed TB within the period 
after taking the IPT regimen as a result of poor adherence to the medication. A number of 
them also expressed uncertainty about the effectiveness of IPT in complete TB prevention. 
The participants pointed out that there was limited or no evidence from the local context on 
the effectiveness of IPT and reported having few TB cases during IPT and upon treatment 
completion. This was said to lower their confidence and raise doubts with the intervention. 
The need for additional evidence from the local context was recommended to build 
confidence and comfort with the intervention. 
“…You will not be able to monitor these patients considering that they know that they 
don’t have TB, adherence will be affected… I am not very comfortable with IPT…In 
case the IPT fails, I risk the patient getting MDR, of which they will have to cough 
some money…” (health care provider, KNH) 
“…That is always my question when I find someone that has been on isoniazid now 
coming with signs of TB or being confirmed to be having TB. You just give but you 
really wonder whether you are doing the right thing.”(health care provider, Mama 
Lucy Kibaki Hospital) 
“Also, I wish that more research will be done on the uptake. We want to see what 
numbers, as much as they’ve been on IPT, what percentage of clients are still 
developing TB?...”(health care provider, Mbagathi District Hospital) 
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Discomfort with IPT duration 
Health care providers largely expressed dissatisfaction with the long duration of the IPT 
treatment regimen and considered it a major factor that affected their comfort with the 
intervention. Most of them recommended a reduced duration of the drug with the help of 
suitable research. This was because of pill-burden and adverse effects reported by the patients 
to the providers.  
“…you see the shorter the period that one takes the drugs, the better. So I would be of 
the opinion that if research could be carried out to at least shorten the period of 
giving IPT or even if it involves changing the drugs themselves...” (health care 
provider, KNH) 
“If I had a chance, I would give an IPT that would be taken once. Not the daily one 
for six months. That’s a long time...” (health care provider, Mama Lucy Kibaki 
Hospital) 
Discomfort with IPT initiation procedures 
Some of the participants reported that the procedures involved in IPT initiation resulted in 
irregularities in IPT implementation and increased workload. A number of examinations on 
the patients had to be performed before prescription of IPT and the fact that these tests were 
conducted elsewhere and not in the CCC caused delays and loss of some patients. Heath care 
providers recommended better integration of IPT-related services i.e. clinical examinations 
within the clinic and a separate department developed dedicated to IPT initiation and follow-
up in order to make them more comfortable with initiation procedures. 
“Then, if you can follow the standard operating procedure to give IPT, it will take 
you very long to complete all those investigations, examinations and what have you… 
The procedure becomes too long…Will you give that IPT?” (health care provider, 
KNH) 
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3.1.3. Provider-related factors 
Factors related to the health care providers themselves were considered to affect the 
perception and implementation of IPT in the clinics. 
Provider information/ training on IPT 
 Health care providers indicated that they required more information and training on IPT in 
order to be more empowered and comfortable with the intervention. They cited discomfort or 
uncertainty with different IPT-related activities due to lack of information and evidence on 
the same. They recommended revision of guidelines and more training on IPT, driven by 
policy makers as well as regular monitoring and reporting of IPT outcomes from research.  
 “…Some of us have not been taken through training on IPT. It was just introduced 
and you are told, “Give IPT for this duration”… So I feel we should have been taken 
through a training to know more about the IPT even before rolling it out.” (health 
care provider, KNH) 
“I can talk about the level of training on IPT. Especially in paediatric 
IPT…Personally I don’t have enough information on the safety of this IPT in 
pregnancy…The experiences that the patients report make me hesitant to continue to 
prescribe to other patients.” (health care provider, Mbagathi District Hospital) 
 
Peer influence on IPT perceptions 
Peer influence also affected the perception of health care providers about IPT. The 
satisfaction of other health care workers with the intervention contributed to that of other 
health care providers. Negative perceptions or doubts about the intervention by other health 
care workers affected the perception and delivery of IPT by the fellow providers.  
“…Colleagues say that patients tell them “I’ve seen a friend of my husband who 
took…”,you know. So that experience with my colleagues from the patients’ mouth 
talking. In fact, part of it was the reason why Mbagathi delayed as a hospital to start 
IPT.” (health care provider, Mbagathi District Hospital) 
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“…because it’s like you feel like you’re the only one who is pressuring people to take 
IPT, or you’re really encouraging patients to take IPT…So sometimes you feel 
discouraged like, “Ah! After all nobody is giving”…” (health care provider, Mama 
Lucy Kibaki Hospital) 
3.1.4. Patient-related factors 
Factors relating to the patients were thought to considerably affect health care providers’ 
perceptions and delivery of IPT.  
Patients’ side-effects and non-adherence to IPT 
Participants mentioned non-adherence of the patients to the medication as a factor that 
affected their perception on IPT. Non-adherence was believed to be as a result of fear of side-
effects and pill burden among the patients. Participants expressed concern that non-adherence 
would eventually lead to development of resistance to isoniazid among the patients in the 
long run. They reported development of serious side effects among patients that affects 
adherence of other patients. Due to this, some health care providers reported basing their 
decision to deliver IPT on the immunological, virological and clinical state of the patients, 
while some considered the drug regimen of the patients. This made a number of health care 
workers hesitant in initiating IPT. They recommended considerations of patient clinical state 
and drug regimen it to be added to the IPT guidelines as well. 
“…They are getting some rumours and misconceptions that when you take those 
prophylaxis for TB, when you get TB, it will develop resistance, then they throw the 
drugs away. They tell you they are taking the drugs.”( health care provider, KNH) 
“…At least for them to do a research and find out if these side-effects are really 
associated with IPT. But if it is found to be safe to use, I would not have any other 
recommendations…Uptake reduced because they were not starting anyone else on 
IPT for fear of side-effects and death.” (health care provider, KNH) 
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Pill burden among patients 
Health care providers also felt that Isoniazid increased the pill burden among the patients 
which affected their adherence to the medication. Patients complained of the difficulty in 
consuming the medication while some completely declined to take the medication due to high 
number of pills. As a result, they recommended that a shorter duration formulation of IPT for 
the patients would help tackle this problem.  
…“So due to that you find that there is sort of pill burden. Yeah, patients feel that 
these drugs are so many. And some say they don’t want to start these drugs 
together…” (health care provider, KNH) 
“…I was thinking like, if they can review the concentration now, then may be find out 
the concentration that can still work and still be mild to the patients…because of the 
pill burden to these clients...” (health care provider, Mbagathi District Hospital) 
Inadequate patient information on IPT 
Information about the benefits and effects of IPT was reported to be limited among the 
patients. Rumours and misconceptions about IPT among the patients were thought to strain 
the IPT program with patients refusing to be initiated or disposing the medication even after 
being briefed about it. Providers expressed concern over the lack of consensus and support 
regarding patient education activities in the CCCs for IPT and recommended intervention 
from stakeholders and policy makers. 
“…and also lack of understanding. “Why should you give me?”…Inadequate 
information....We conduct Continous Medical Education (CME), then we formulate 
something. Information which should be given to the patient and how the information 
should be given…” (health care provider, KNH) 
“I think they need to do more education to the people. ‘Actually most of the clients 
they decline because they have never heard about it…“I am being treated for TB yet I 
don’t have TB signs.”...” (health care provider, Mama Lucy Kibaki Hospital) 
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3.1.5. Structural and operational factors 
Structural factors relate to the physical and working environment of the health care providers. 
Most frontline providers expressed discomfort with the working environment and 
consequently suggested changes with regard to the structuring and lay out of IPT related 
services.  
 
Poor integration of IPT-related services 
Health care providers reported poor integration of IPT services in the clinic that affected the 
program. They felt that clinical examinations required before IPT initiation should be 
performed in the same facility and subsidized in terms of cost so that all patients undergo the 
tests to ascertain eligibility for IPT. They considered this a role of the management and policy 
makers to ensure that the IPT program was effectively implemented. 
 “…It will even be faster for the patients. Because if we do the tests from here, it will 
take like 30 minutes to do everything and give the patient IPT. When they come again 
for check-ups, we can still do them again from here, and it takes less time and we get 
results in real time.” (health care provider, KNH) 
“Number one is lack of space in our facility. We do not have enough space to 
accommodate all services that we provide… now since they have to move around the 
hospital, some of them, they kind of disappear along the way…” (health care 
provider, Mama Lucy Kibaki Hospital) 
Increased workload 
Front line providers complained of the high workload in the facility which they felt 
negatively affected the IPT program. They were concerned with the limited number of 
clinicians and the high volume of patients in the CCC. The procedures involved before IPT 
initiation were considered very long and hence a burden to be managed and monitored by a 
single clinician. Providers felt that more clinicians should be hired with some dedicated to  
IPT related activities in the CCCs. 
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“…You see now by the time you do all this screening for like hepatitis, 
what…what…convincing the patient to start IPT. You see now it becomes a big work 
load because we have many patients waiting in line to be served.” (health care 
provider, KNH) 
“To comment about the environment and the working condition, here as a national 
referral, we have very high workload. Then, if you can follow the standard operating 
procedures to give IPT, it will take you very long to complete all those investigations, 
examinations and what have you… ” (health care provider, KNH) 
Poor INH drug supply 
Most of the health care providers also mentioned stock-out of Isoniazid medication and other 
supplies related to the IPT program in the facilities. They reported stock-outs in the previous 
year and considered this as a factor that greatly affected delivery of IPT to the patients. The 
providers felt that the erratic stocks and poor supply chain of the medications indicated poor 
support and monitoring of the IPT program by the policy makers and management, which 
lowered their morale and affected their perception and delivery of the medication to the 
patients.  
“…We had started the program nicely. We are empowering patients, we are 
counselling them on IPT, we are encouraging them to take IPT. And then all of a 
sudden from nowhere, IPT is no more” (health care provider, Mama Lucy Kibaki 
Hospital) 
“My biggest challenge with the management is when there is erratic supply of 
IPT…So the patients were out of medication for some time and when you send them 
out to buy them, of course it’s not possible for them to get the drug...” (Clinical 
Officer, Mbagathi District Hospital) 
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3.2. Measuring the acceptability of IPT among health care providers 
(Quantitative survey results) 
Summary of key findings  
The overall acceptability score was 73% on average among health care providers from the 
three HIV clinics, which was categorized as moderate acceptability. Patient and intervention-
related factors showed a significant relationship with the acceptability scores in the 
multivariable linear regression. 
3.2.1. Demographic characteristics of the study population 
Table 3.2 presents selected characteristics of the study population. A total of 74 health care 
providers were enrolled and participated in the survey. Kenyatta hospital CCC had the most 
participants (30) then Mama Lucy hospital CCC (23) and Mbagathi hospital CCC had the 
least participants (21). Out of these, 32% participants were male and 68% were female. 
Majority of the healthcare providers (70%) were below 40 years of age with the median age 
of the study population being 35 years (IQR: 27 - 43). Most of the participants had more than 
4 years working experience in providing HIV and TB care (60.81 %). Clinical officers, 
nurses and counsellors were the cadres with most participants, accounting for 20%, 23% and 
20%, respectively. Frontline providers (clinical officers, nurses and pharmacists) accounted 
for 53% of the study population while non-frontline providers (counsellors, peer educators, 
medical social workers, nutritionists, clinical psychologists and laboratory scientists) 
accounted for 47%. IPT uptake in the three facilities stood at 56% in Kenyatta hospital CCC, 
17% in Mama Lucy hospital CCC and 18% in Mbagathi hospital CCC. 
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Table 3.2 Demographic characteristics of health care providers in the study population 
 Kenyatta Mbagathi Mama Lucy  Total 
Variables n=30 (%) n=21 (%) n=23 (%) N=74 (%) 
Gender     
Male 12 (16.2) 4 (5.4) 8 (10.8) 24 (32.4) 
Female 18 (24.3) 17 (23) 15 (20.3) 50 (67.6) 
     
Age (years)     
< 30 8 (10.8) 14 (18.9) 7 (9.5) 29 (39.2) 
31-40 12 (16.2) 3 (4.1) 8 (10.8) 23 (31.1) 
> 40 10 (13.5) 4 (5.4) 8 (10.8) 22 (29.7) 
     
Job category     
Clinical officer 8 (10.8) 4 (5.4) 3 (4.1) 15 (20.3) 
Nurse 8 (10.8) 4 (5.4) 5 (6.8) 17 (23.0) 
Pharmacist 5 (6.8) - 2 (2.7) 7 (9.5) 
Counsellor 3 (4.1) 9 (12.2) 3 (4.1) 15 (20.3) 
Peer educator 1 (1.4) 2 (2.7) 4 (5.4) 7 (9.5) 
Medical social worker 2 (2.7) - 2 (2.7) 4 (5.4) 
nutritionist - 2 (2.7) 3 (4.1) 5 (6.8) 
Clinical psychologist 2 (2.7) - - 2 (2.7) 
Laboratory scientist 1 (1.4) - 1 (1.4) 2 (2.7) 
     
Years of experience in HIV/TB 
care 
    
< two years 2 (2.7) 7 (9.5) 1 (1.4) 10 (13.5) 
2-4 years 4 (5.4) 9 (12.2) 6 (8.1) 19 (25.7) 
> 4 years 24 (32.4) 5 (6.8) 16 (21.6) 45 (60.8) 
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Figure 3.2 Bar graph of IPT uptake among health care providers in the three HIV 
clinics (% of total patients enrolled in care in the clinics) 
3.2.2. Acceptability of IPT among health care providers from selected HIV clinics 
The overall median acceptability score in the study population was 73% (IQR: 58-80) while 
the overall mean and standard deviation was 70.33% (12.79). The range of the acceptability 
scores was between 44% and 93%. The distribution of acceptability scores within the study 
population is shown in the box plot in Figure 3.2. A histogram showing the distribution of the 
acceptability scores among the study participants is also presented in Figure A1 of Appendix 
A.  The acceptability scores were observed to follow a normal distribution from the bell-
shaped normality curve overlaid on the histogram. 
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Figure 3.3 Box plot of acceptability scores of IPT among health care providers 
The distribution of the three tertiles to rank the acceptability scores are shown in Table 3.3 
and Figure 3.3. The mean acceptability scores were 55% (SD: 4.5), 73% (SD: 4.4) and 85% 
(SD: 4.6) for the low, moderate and high acceptability tertiles respectively.  
Table 3.3 Acceptability scores by category 
 
Acceptability category 
 
Range 
Number of 
observations 
 
Mean (SD) 
 
Median (1QR) 
 
Overall score 
 
44-93 
 
74 
 
70.3 (12.8) 
 
73 (58-80) 
Low 44-63 25 55.1 (4.5) 56 (53-58) 
Moderate 64-79 28 73.0 (4.4) 74.5 (69-76) 
High 80-93 21 85.0 (4.6) 84 (80-87) 
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. Figure 3.4 Box plots of acceptability scores by tertile 
Table 3.4 shows the acceptability levels of IPT among health care providers by selected 
characteristics. The level of acceptability of IPT varied across the study population. 28% 
expressed high acceptability, 38% expressed moderate acceptability while 34% showed low 
acceptability of IPT). The highest mean acceptability scores were observed in Mama Lucy 
Hospital CCC (78.14%), followed by Mbagathi District Hospital CCC (74.13%), then 
Kenyatta hospital CCC (61.97%) having the lowest mean acceptability scores. Non-frontline 
providers (counsellors, Peer educators, medical social workers and nutritionists) accounted 
for higher mean acceptability scores (75.88%) than frontline providers (clinical officers, 
nurses and pharmacists) whose mean value was 65.88%. A detailed graph of acceptability 
score by job cadre is presented in Figure 2 in appendix A. 
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Table 3.4 Acceptability levels of IPT among health care providers by selected 
characteristics 
 
 
 
Variables 
 
Acceptability 
Score 
Mean (SD) 
High 
acceptability 
n (%) 
21 (28.38) 
Moderate 
acceptability 
n (%) 
28 (37.84) 
Low 
acceptability 
n (%) 
25 (33.78) 
 
Total 
N (%) 
74 (100) 
      
Facility      
    Mbagathi 78.1 (8.9) 20 (27.03) 7 (9.46) 3 (4.05) 30 (40.54) 
    Kenyatta 62.0 (11.1) 1 (1.35) 9 (12.16) 11 (14.86) 21 (28.38) 
    Mama Lucy 74.1 (11.9) 4 (5.41) 12 (16.22) 7 (9.46) 23 (31.08) 
      
Sex      
    Male 68.1 (12.1) 3 (4.05) 13 ( 17.57) 8 (10.81) 24 (32.43) 
    Female 71.4 (13.1) 18 (24.32) 15 (20.27) 17 (22.97) 50 (67.57) 
      
Age       
    < 30 74.4 (10.4) 11 (14.86) 12 (16.22) 6 (8.11) 29 (39.19) 
    31-40 66.1 (11.2) 2 (2.70) 13 (17.57) 8 (10.81) 23 (31.08) 
    41-50 69.4 (15.8) 8 (10.81) 3 (4.05) 11 (14.86) 22 (29.73) 
      
Job category      
    Frontline  66.2 (12.9) 7 (9.46) 14  (18.92) 18 (24.32) 41 (55.41) 
    Non-frontline  75.0 (11.0) 14 (18.92) 14 (18.92) 7 (9.46) 33 (44.59) 
      
Years of 
experience in 
HIV/TB care 
     
   <1  77.7 (7.3) 4 (5.41) 5 (8.11) 1 (1.35) 10 (13.51) 
    2-4  73.3 (13.1) 8 (10.81) 5 (8.11) 6 (8.11) 19 (25.68) 
   > 4  67.5 (12.9) 9 (12.16) 18 (24.32) 18 (24.32) 45 (60.81) 
 
 
3.3. Relationship between acceptability of IPT and identified determinants 
3.3.1. Description of determinants of acceptability of IPT among health care providers 
The five groups of determinants of acceptability in the framework in Figure 2.1 are: policy 
and guideline-related, patient-related, provider-related, intervention-related, structural and 
operational factors. The Chronbach’s alpha values of these determinants as well as participant 
responses are as shown in Table 3.5. An average of the components of each determinant is 
generated to produce a single value for the determinant for each respondent. 
43 
 
Table 3.5 Description and internal consistency of determinants of acceptability of IPT 
Category Variables/ questionnaire items SA 
n (%) 
A 
n (%) 
Neither 
n (%) 
D 
n (%) 
SD 
n (%) 
Chronbach’
s α value 
Policy/Guid
elines 
Policy makers consulted with HCP (introduction)  8 (10.8) 16 (21.6) 15(20.2) 22 (29.7) 13(17.6) 0.5281 
Policy makers consulted with HCP (Revision) 9 (12.6) 21 (29.4) 17(23) 16 (21.6) 11 (14.9)  
Pressure from policy to implement IPT 17 (23) 29 (39.2) 16(21.6) 11 (14.9) 1 (1.4)  
Intervention IPT may develop resistance 15(20.3) 25 (33.8) 17 (23) 11 (14.9) 6 (8.1) 0.6124 
Concerned about adverse effects and/or deaths. 21(28.4) 31 (41.9) 6 (8.1) 9 (12.2) 7 (9.5)  
More research required on effectiveness 39(52.7) 31 (41.9) 1 (1.4) 3 (4.1) 0  
Procedure before delivery lengthy 8 (10.8) 16 (21.6) 17 (23) 26 (35.1) 7 (9.5)  
Provider Require more training 35(47.3) 34 (46) 5 (6.8) 0 0 0.5380 
Require more evidence on IPT effectiveness 30(40.5) 27 (36.5) 4 (5.4) 11 (14.9) 2 (2.7)  
Require more evidence on adverse effects & deaths 32(43.2) 34 (46) 4 (5.4) 3 (4.1) 1 (1.4)  
Colleagues are positive about IPT 2 (2.7) 17 (23) 18(24.3) 27 (36.5) 10 (13.5)  
Patient Patients adhere to IPT 5 (6.8) 14 (18.9) 7 (9.5) 33 (44.6) 15 (20.3) 0.7287 
IPT increases pill burden 29(39.2) 25 (33.8) 6 (8.1) 9 (12.2) 5 (6.8)  
Patients require more information 49(66.2) 22 (29.7) 1 (1.4) 2 (2.7) 0  
Clinical state should be considered before IPT 1 (1.4) 4 (5.4) 2 (2.7) 28 (37.8) 39 (52.7)  
Drug regimen should be considered before IPT 2 (2.7) 8 (10.8) 3 (4.1) 30 (40.5) 31 (41.9)  
Patients develop severe side-effects 7 (9.5) 26 (35.1) 20 (27) 19 (25.7) 2 (2.7)  
Patients refuse to take IPT 7 (9.5) 34 (46) 14(18.9) 14 (18.9) 5 (6.8)  
Structural IPT related services well integrated 3 (4.1) 8 (10.8) 6 (8.1) 37 (50) 20 (27) 0.6014 
The working environment in the clinic is very 
comfortable 
1 (1.4) 8 (10.8) 6 (8.1) 38 (51.4) 21 (28.4)  
Operational There is high workload 13(17.6) 23 (31.1) 10(13.5) 23 (31.1) 5(6.8)  
We experience INH stock out 27(36.5) 28 (37.8) 8 (10.8) 11 (14.9) 0  
The supply chain of INH and other IPT-related 
supplies is effective. 
4 (5.4) 23 (31.1) 15(20.3) 25 (33.8) 7 (9.5)  
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3.3.2. Relationship between acceptability scores and determinants 
Unadjusted analysis was performed to observe the independent relationship between the 
determinants and acceptability scores while the adjusted model included both determinants of 
acceptability and demographic characteristics of health care providers. The results are 
presented in Table 3.5.  
Variables significantly associated with acceptability scores in the unadjusted model include 
job category, years of experience, policy/guideline-related factors, patient factors, provider 
factors and intervention-related factors. In summary, non-frontline providers show higher 
acceptability scores on average as compared to frontline providers (Coeff: 8.79; 95% CI 3.18- 
14.40). Compared to those with less than two years’ experience in HIV/TB care, health care providers 
with more than four years of experience show higher acceptability scores on average (Coeff: 10.23; 
95% CI -18.86--1.61). For the determinants, a unit increase in the policy/guideline, patient, provider, 
and intervention factor scores leads to an increase in the acceptability scores by 4.70% (1.45 - 7.96), 
15.72% (10.20 - 21.23), 11.20% (6.73 - 15.66) and 7.95% (4.46 - 11.44) on average respectively. 
Patient and intervention-related factors are significantly associated with the acceptability 
scores in the adjusted model. A unit increase in the patient factors score leads to an increase 
in the acceptability score by 5% on average (95% CI -0.39– 10.63; P=0.050). Similarly, a unit 
increase in the intervention-related factors score leads to an increase in the acceptability score 
by 7% on average (95% CI 3.42– 10.01; P=0.000). 
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Table 3.6 Crude and adjusted coefficients of determinants of acceptability of IPT 
among health care providers in selected HIV clinics 
Variable 
Unadjusted Coefficients 
Coeff  (95% CI) 
 
p-value 
Adjusted Coefficients 
Coeff  (95% CI) 
 
p-value 
     
Sex 
 
 
 
 
      Male (ref) 0.00 - 0.00 - 
Female 3.28 (-3.05-9.60) 0.31 0.11 (-4.44 - 4.66) 0.96 
     
Age (Years) -0.17 (-0.47 – 0.12)  -0.13 (-0.38 – 0.11) 0.28 
     
Job category 
 
 
 
 
     Frontline (ref) 0.00 - 0.00 - 
non-frontline 8.79 (3.18-14.40) 0.003* 0.83 (-3.96 – 5.62) 0.35 
     
Years of experience 
 
 
 
 
      < 2 years (ref) 0.00 - 0.00 - 
2-4 years -4.44 (-14.07- 5.20) 0.36 -5.29 (-12.53 - 1.95) 0.15 
> 4 years 10.23 (-18.86--1.61) 0.02* -4.41 (-12.34 - 3.52) 0.27 
     
Policy/Guidelines 4.70 (1.45 - 7.96) 0.01* 0.25 (-2.43 - 2.94) 0.85 
  
 
 
 
Patient factors 15.72 (10.20 - 21.23) 0.00* 5.12 (-0.39 - 10.63)  0.05* 
  
 
 
 
Provider factors 11.20 (6.73 - 15.66) 0.00* 3.06 (-1.08 – 7.20) 0.16 
  
 
 
 
Structural/ operational 
factors 1.81 (-2.67 - 6.28) 
 
0.42 -0.24 (-3.84 - 3.37) 0.90 
  
 
 
 
Intervention 7.95 (4.46 - 11.44) 0.00* 6.72 (3.42 - 10.01) 0.00* 
R-squared (adjusted)=65.4%; ref = reference category; CI=95% confidence interval;                   
* Significant at p ≤ 0.05; coeff=coefficients 
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CHAPTER 4: DISCUSSION 
4.0.  Introduction 
This study is among the first to assess the factors influencing the acceptability of IPT among 
health care providers in selected HIV clinics in Nairobi County, Kenya. From the study, 
factors influencing the acceptability of IPT fell into six broad categories; policy/guideline-
related, intervention-related, patient-related, provider-related, structural and operational 
factors. Patient and intervention-related factors emerged as significant in the quantitative 
enquiry.  
4.1. Acceptability of IPT among health care providers 
Acceptability of IPT among health care providers in the HIV clinics was found to be 
moderate. The health care providers did not find the intervention fully comfortable, agreeable or 
satisfactory to use, which was influenced by different factors at different levels.  If the delivery of 
an intervention is considered to have low acceptability, the intervention may not be delivered 
as intended, which would impact its overall effectiveness (43, 59). Furthermore, acceptability 
is a proximal indicator of IPT uptake and may be used to model implementation success of 
the intervention (25). This finding therefore warrants further investigation on the implication 
of acceptability levels to the delivery of IPT. The literature indicated a paucity of studies 
assessing the acceptability of IPT in the Kenyan context and the few studies on IPT 
implementation in Kenya have shown sub-optimal implementation of the intervention (64). 
The use of a context specific tool is not unique to our study. Quantitative studies on 
acceptability have employed adapted context specific tools (53, 65).  
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4.2. Factors influencing the acceptability of IPT among health care providers. 
Factors influencing acceptability of IPT emanating from the study were in agreement with 
those presented in the implementation literature. A review by Durlak and Dupre, 2008 and a 
synthesis by Damshroder et al. 2009 found that factors influencing implementation outcomes 
comprised patient, structural, organizational, provider and innovation-level (56, 57). Notably, 
the qualitative findings were consistent with those from some of the studies conducted to 
assess the implementation of IPT in low-resource settings. 
4.2.1. Policy/ guideline-related factors affecting the acceptability of IPT 
Consistent with the study findings, lack of commitment to the IPT programme by higher 
managers and policy makers has emerged from other studies as a factor that influenced IPT 
implementation (10, 38). Poor monitoring and lack of supervision of the IPT program by 
higher managers has been found to influence IPT uptake (10, 37). Participants expressed 
discomfort with IPT guidelines and SOPs in the facilities and felt that there was pressure 
from policy makers to implement the intervention This echoes other studies whereby no 
availability or lack of clarity of guidelines was found to be a major barrier to IPT 
implementation (37, 39). Identification of latent TB has emerged as a challenge that affected 
IPT implementation in low-resource settings, and health care providers have called for clarity 
of guidelines (45). Development of operational guidelines and strong policy presence has 
been considered essential for effective IPT implementation (44, 66). The quantitative enquiry 
did not show a significant relationship between policy and guideline-related factors and the 
acceptability score. However, the importance of policy makers and guidelines in the 
implementation of evidence-based interventions has been emphasized as well as the 
interaction between policy makers and practitioners to ensure effective implementation of 
IPT (15, 67). 
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4.2.2.  Intervention-related factors affecting the acceptability of IPT 
Factors concerning the interventions themselves affect the implementation outcomes of 
evidence-based interventions in health care (56-58). This lends support to our findings that 
intervention-related factors greatly influenced the acceptability of IPT among the health care 
providers. The few studies conducted in sub-Saharan Africa to date have found fear of drug 
resistance among health care providers, patients and policy makers as an important 
influencing factor of IPT implementation, especially driven by high prevalence of MDR and 
XDR-TB in these contexts (37, 44, 68). This finding, despite this study being largely 
exploratory, is cause for concern with the gradual increase in drug-resistant TB cases in 
Kenya from 112 to 433 in 2015, as reported by the NTLD-Program (20). Both rifampicin and 
Isoniazid resistance has been reported in the pulmonary and extra pulmonary TB cases, 41% 
of whom were co-infected with HIV and TB (20). Uncertainty on the effectiveness of IPT in 
preventing TB, discomfort with the duration and the difficulty with IPT-related activities and 
procedures were also found the influence acceptability of the intervention. A 2009 study on 
the implementation of CTXp and IPT policy recommendations among 69 high burden 
countries for HIV infection found uncertainty on the long term benefits of IPT among policy 
makers as one of the key impediments to the implementation of IPT policy nationally (44). 
Similarly, prescribers were unaware of the benefits of IPT and unclear about guidelines in a 
2010 Ethiopia study (37). Intervention-related factors were significantly related to the 
acceptability of the intervention in the quantitative enquiry. Investigation of optimal duration, 
safety and efficacy of IPT and its role in reducing the risk of active TB, particularly under 
programme conditions has been strongly recommended by the WHO, Stop TB plan (36).  
4.2.3. Provider-related factors affecting the acceptability of IPT  
Provider-level factors have been hypothesized to predict implementation outcomes from 
rigorous reviews of empirical results as well as existing conceptual frameworks (56, 57). 
Limited information and empowerment on IPT was found as an influencing factor to the 
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acceptability of IPT. This is consistent with other studies conducted in sub-Saharan Africa. A 
study conducted in South Africa found lack of knowledge and experience with IPT to be the 
primary barrier to IPT implementation (37). Similarly, lack of training and guidelines was a 
considered an influencing factor of IPT implementation in a 2016 mixed methods study 
conducted in Ethiopia (10). Providers form part of the prevention delivery system who 
implement innovations in the field, according to the ISF. Training and information regarding 
an innovation should be adequately provided by the support system before implementation to 
achieve the desired outcomes (18). Similarly, technical assistance was recommended by 
Durlak and Dupre, 2008 to be important once implementation has begun including retraining 
of the providers, training new staff, emotional support, and mechanisms to promote local 
problem solving (56). The NIRN implementation drivers contain training as one of the 
important competency drivers to produce consistent use of innovation and reliable outcomes 
(69). Perceptions of health care providers were affected by the attitudes and perceptions of 
their colleagues. Innovation climate for implementation has been reported in the literature to 
affect the implementation of health innovations (58). Providers recommended more research 
and dissemination of evidence on the effectiveness of IPT and program outcomes from the 
local context. This has also been mentioned as a recommendation of other studies on IPT 
implementation by health care practitioners as well as policy makers (44). 
4.2.4. Patient-related factors affecting the acceptability of IPT 
Patient-level predictors explain meaningful variance in implementation outcomes and are 
considered important factors that must be measured when assessing the implementation of 
interventions (58). Patient-related factors identified from this study included poor adherence, 
pill burden, lack of adequate information on IPT and fear of adverse effects among the 
patients. These findings are consistent with studies that have been conducted in the sub-
Saharan African context on IPT implementation. A recent study conducted in Kenya found 
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fear of TB acquisition and relationship with health care providers as factor that influenced the 
initiation of IPT among patients (64). Teklay et al. 2016 found drug side-effects, pill burden 
and poor adherence among patients to be barriers to the implementation of IPT in an 
Ethiopian setting (10). INH has been reported from randomized studies to have some side-
effects. Adherence to IPT treatment is a critical factor that needs to be considered when 
scaling up treatment services in developing countries (70, 71). A long-standing question that 
has caused uncertainty among policy makers, health care providers and practitioners has been 
the implications of adherence to drug-resistant TB disease especially in the case of long 
course INH mono-therapy (70). Policy makers have indicated that concerns regarding 
inadequate patient adherence potentially leading to INH mono-resistance was a barrier to 
national IPT policy implementation (44). A study conducted in resource-constrained settings 
in Addis Ababa found poor adherence to be an influencing factor to IPT implementation in 
addition to lack of patient empowerment and proper counselling for IPT by health care 
providers (38). A study conducted in Zimbabwe assessing a district’s IPT programme 
implementation found cessation of IPT due to INH toxicity, development of TB during IPT 
and pill burden for the HIV patients as influencing factors to implementation (39). Patient-
level factors emerged from the quantitative survey to have a significant relationship with the 
acceptability scores of the participants, which reiterates the importance of these factors in the 
acceptability of IPT in this context. As in the study, advocacy for IPT at national and 
international level has been recommended to improve information on IPT among patients in 
order to boost uptake (44). The Global Plan to Stop TB has also recommended the 
investigation of implementation of IPT recommended policies on the proportion of PLHIV 
who develop TB disease and mortality  (36). 
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4.2.5.  Structural and operational factors affecting the acceptability of IPT 
Health care providers requested better integration among IPT-related services to enable 
smoother operations in the facility. These findings are not unique to this study alone. For 
instance, Lester et al. found lack of coordination between TB and HIV activities as a barrier 
mentioned by staff to IPT implementation (37). A similar study indicated that performing, 
reading and interpreting TSTs in the context of busy HIV clinics was a challenge for both 
patients and staff and hence affected the IPT program (45). Likewise, a policy-
implementation study of IPT found logistic difficulties in diagnosing latent TB infection as 
one of the barriers affecting implementation (44). Heavy workload for the clinicians and INH 
stock-outs in the HIV clinics has been reported from other studies to affect IPT 
implementation, which is consistent with our findings. Evaluation of the IPT program in a 
district in Zimbabwe reported health workers’ being overwhelmed by other competing 
programs apart from IPT that compromised the quality of implementation (39). This 
inadequacy of formally trained staff compromises the quality of HIV/TB care, which includes 
the IPT program (39). A major problem with IPT implementation in studies conducted is the 
stock-out of INH in the facilities. This emerged as a major influencing operational factor 
from our study. INH supply for the intervention has been reported to be irregular in different 
studies which affected the implementation of the intervention (10, 39).  
4.3.  Implications of the study findings to policy and practice 
This study has many implications for policy makers, IPT program managers and health care 
providers in the study sites. 
The findings of the study highlight the need for further research on the implementation of IPT 
in Kenya. IPT program managers and health care providers both have a role to play in 
promoting successful implementation of IPT to ensure that intended patient outcomes are 
achieved. This includes ensuring that the intervention is fully acceptable among health care 
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providers as well as patients. Program managers should collaborate with researchers to 
conduct further studies on IPT implementation to identify key barriers and facilitators of IPT 
implementation.  
The study also highlights the important role that health care providers play in the 
implementation of IPT.  While health care providers receive implementation guidelines from 
the policy makers, they should be involved every step of the way, from development to 
revision of guidelines for IPT, being the frontline implementers who deliver the intervention. 
This can be achieved through data driven decision making from the health facilities which is 
a key recommendation from the study.  
4.4.  Limitations of the study 
Since the study was context specific leading to the development of a tool, the findings 
emanating from the study are not expected to be reproduced in other HIV clinics in Nairobi 
County. However, it is expected that the tool can be adapted for collection of acceptability 
data in different contexts. Additionally, the study findings cannot be generalised to other HIV 
clinics in Nairobi County since the facilities were purposefully selected for the study.   
The small sample size for the quantitative survey may have limited the ability to detect an 
existing effect of the explanatory variables on the outcome. In this case, the failure to observe 
a possible association between determinants of acceptability and acceptability scores. Only 
two determinants were significantly associated with the acceptability scores in the 
quantitative inquiry which may have been due to the effect of small sample size. However, 
while the qualitative inquiry gave an understanding of factors affecting acceptability of IPT, 
the quantitative survey served to present the magnitude of this relationship.  
This study was conducted among city hospitals which are assumed to be better resourced than 
those in other locations. Therefore, the IPT program was expected to be better managed as 
opposed to other non-city facility clinics. This could contribute to over-reporting of 
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acceptability levels of IPT among the providers. Hence, the acceptability findings were 
context specific to the selected HIV clinics. 
4.5.  Strengths of the study 
Despite the aforementioned limitations, the study has a number of strengths. 
Firstly, the study employed mixed methods which provided a better understanding of the 
acceptability of IPT among health care providers than would have been possible with either 
qualitative or quantitative methods alone.  
Furthermore, the data collection for the study was guided by existing theoretical frameworks 
for implementation research and acceptability measurement. This helped to increase validity 
of the study and further demonstrates the feasibility of using quided theories and frameworks 
in tool development for implementation research. 
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CHAPTER 5: CONCLUSION AND RECOMMENDATIONS 
 
5.1. CONCLUSION 
In conclusion, IPT is not considered fully comfortable, agreeable or satisfactory to use by 
health care providers in the context of three HIV clinics in Nairobi County. This is influenced 
by different factors at different levels. 
The use of mixed methods enabled the elucidation of context specific factors that influenced 
acceptability as well as presenting a clear picture of the implementation outcome. The 
feasibility of using theoretical frameworks to guide the assessment of implementation 
outcomes has also been demonstrated in the study. 
Factors that influenced the acceptability of IPT in the HIV clinics included policy/guideline-
related factors, patient-related factors, provider-related factors, intervention-related factors, 
structural and operational factors. Notably, patient and intervention-related factors emerged 
as important predictors of acceptability as they were significantly related to acceptability 
scores in the quantitative survey. 
5.2. RECOMENDATIONS 
1. The results from this exploratory study give prospects for further research on the 
implementation of IPT by health care providers in HIV clinics. Considering the 
limitation to generalizability of our study findings, the study should be scaled up in 
Nairobi County and other high HIV and TB burden settings in Kenya. 
2. Development of operational guidelines and strong policy presence are required to 
improve the acceptability of IPT among health care providers in the clinics. This may 
be achieved through collaboration and concerted efforts among policy-makers, 
program managers and health care providers from the HIV clinics. The fact that health 
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care providers expressed discomfort with guidelines and perceived a lack of 
commitment to implement the intervention should be concerning. This calls for 
operational research and data-driven decision making by policy makers and program 
managers on factors affecting implementation of IPT in the context of the three HIV 
clinics. 
3. As an initial step to improve the acceptability of IPT among health care providers in 
the HIV clinics, patient and intervention-related influencing factors should be acted 
upon by program managers in collaboration with facility administrators and health 
care providers. This will effectively require advocacy for IPT and dissemination of 
context-specific information regarding benefits of IPT among providers and patients. 
This requires a strategic plan developed among stakeholders involved to improve IPT 
acceptability considering all the identified factors. 
4. The research has demonstrated the feasibility of assessment of acceptability using a 
context-specific quantitative tool guided by existing frameworks. It is recommended 
that future research should consider adapting the tool in their measurement of 
acceptability. Content and construct validity of the tool as well as reliability tests in 
measuring acceptability among health care workers should be assessed to enable 
repeated measures of acceptability using a single tool. 
5. Lastly, the author recommends the assessment of other implementation outcomes at 
policy-level, organizational and provider-level to give a better picture of IPT 
implementation success and quality. This includes but not limited to the fidelity of 
IPT implementation by health care providers in HIV clinics. Subsequently, the 
feasibility of quality improvement in improving IPT implementation in HIV/TB 
health care settings should be explored. 
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APPENDICES 
APPENDIX A: ADDITIONAL FIGURES 
 
 
. Figure A1 Distribution of acceptability scores across the study population 
 
 
Key: 1=Clinical officer, 2=Nurse, 3=Pharmacist, 4=Counsellor, 5=Peer educator, 6= 
Medical Social Worker, 7=Nutritionist, 8=Clinical psychologist, 9=Laboratory scientist 
Figure A2 Distribution of the mean acceptability scores by job category of the health 
care providers 
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APPENDIX B: INFORMATION SHEET AND INFROMED CONSENT FOR IN-
DEPTH INTERVIEWS 
 
School of Public Health 
University of the Witwatersrand, Johannesburg 
Information sheet  for in-depth interviews. 
 
Good day.  
Introduction: 
My name is Elvis Omondi Achach Wambiya and I am an MSc Epidemiology 
(Implementation Science) student at the School of public Health, University of the 
Witwatersrand, Johannesburg, South Africa.   
Purpose of the study and methods: 
I am conducting a study to assess the acceptability of IPT (Isoniazid Preventive Therapy) 
among health care providers in selected HIV clinics in Nairobi County, Kenya. This research 
is a partial fulfilment of the requirements for the degree of MSc Epidemiology 
(Implementation Science) from the University of the Witwatersrand, Johannesburg, South 
Africa.  The study utilized a mixed methods approach and therefore will involve in-depth 
interviews as well as filling in of a questionnaire. In-depth interviews will be conducted first 
and after analysis, participants will be required to fill a refined questionnaire. 
Invitation to participate: 
As a health care provider in one of the select facilities for the research, you have been 
selected to participate in this interview because we believe that you will be able to provide us 
with valuable information about IPT. We would like to invite you to participate in this study 
and to request your permission to conduct an interview with you.  
We would also kindly request your permission to audio tape record the interview to enable 
analysis of the data and document the findings. The interview will take place in a private and 
conducive location at your convenience. 
I would like to know your thoughts and perceptions about the intervention, as well as factors 
you think affect the way you feel about the intervention. This will include personal/ 
individual views as well as views about how the environment or organization as well as other 
factors affect your perception of IPT. 
Benefits and Risks: 
Though the study has no direct benefit to you, your views will help to highlight the quality of 
TB care that is offered to PLHIV at your clinic. This will not only be useful to health care 
providers and facility administrators but also to policy makers to improve IPT administration.  
There is no anticipated risk of harm from participating in the study. However, if you 
experience any distress following participation you are encouraged to inform the researcher 
and contact the resources provided at the end of this sheet. 
 
63 
 
Confidentiality and anonymity: 
All information will be kept confidential. No one apart from the researcher and supervisors 
will know what you have said. The audio recordings from the interview will be stored in a 
password protected computer for a maximum period of two years after publication of the 
study in a peer-reviewed journal, after which they will be deleted from the computer storage 
entirely. In case the findings are not published, the audio recording will be stored in a 
password protected computer for a maximum period of six years after which they will be 
deleted from the computer storage entirely.  
The typed version of your interview will be made anonymous by removing any 
identifying information including your name from the transcript and allocating a research 
code, known only to the researcher. Any direct quotations from your interview used in the 
research report or publications from the study will be anonymized and your name will not 
appear. All your personal data will be confidential and will be kept separate from your 
interview responses and stored safely in a password protected computer. 
Voluntariness: 
Participation in the interview is voluntary and you are free to withdraw your participation at 
any time during the session without any recourse. Similarly there will be no negative 
consequences if you do not want to be interviewed. You will be asked to sign a consent form 
to show that you voluntarily agreed to take part. 
Reimbursement: 
Please note that there will be no reimbursement for taking part in the interview.  
Duration: 
The interview will take about one and a half hours will be conducted in English language and 
as per your convenience. 
This study has been reviewed by the University of the Witwatersrand Faculty of Public 
Health and the Wits Human Research Ethics Committee (Medical). 
If you have any concerns or questions regarding any aspect of this study, please contact me or 
my supervisors on: 
Elvis Omondi Achach Wambiya 
Tel No. +254797184545 
Email: eowambiya@gmail.com 
 
Dr. Latifat Ibisomi (Supervisor) 
Senior Lecturer and Course Coordinator, 
School of Public health, 
The University of the Witwatersrand. 
Email: Latifat.Ibisomi@wits.ac.za 
 
Dr. Martin Atela (Supervisor) 
Knowledge Translation Scientist - AFIDEP (African Institute of Development and 
Policy), 
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Lecturer – School of public Health, University of Nairobi, 
Nairobi, 
Kenya. 
Email: martin.atela@afidep.org 
In case of any complaint or other concerns about any aspect of this study, please get in touch 
with the Ethics Committee on the following contacts: 
Chairperson: peter.cleaton-jones1@wits.ac.za  
Administrators - Ms Zanele Ndlovu/ Mr Rhulani Mkansi/ Mr Lebo Moeng  
Tel: 011 717 2700/2656/1234/1252  
Email: HREC-Medical.ResearchOffice@wits.ac.za 
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Consent for in-depth Interviews 
I have been presented with the Information sheet for the study on acceptability of Isoniazid 
Preventive Therapy among health care providers in selected HIV clinics in Nairobi County, 
Kenya. I have read and understood the Information sheet and all my questions have been 
answered to my satisfaction.  
 
I understand that it is my decision whether or not to participate in the interview and that there 
will be no negative consequences if I decide not to participate. I also understand that I do not 
have to answer any questions that I am uncomfortable with and that I can stop the interview 
at any time. 
 
I understand that the researchers involved in this project will ensure confidentiality and that 
my name will not be used in the study reports, and that comments that I make will not be 
reported back to anybody else. 
 
Yes, I consent voluntarily to be interviewed    
No, I do not give consent to be interviewed    
Interviewee’s signature:  Date:  
 
Consent to tape record the interview 
I have read the project information sheet, and I understand that it is my decision whether or 
not the interview is tape-recorded. My decision will not affect in any way how the 
interviewer treats me if I do not want the interview to be tape-recorded.  
I understand that if the interview is tape-recorded that the tape will be destroyed two years 
after the interview. 
I understand that I can ask the person interviewing me to stop tape recording, and to stop the 
interview altogether, at any time.  
 
I understand that the information that I give will be treated confidentially and that my name 
will not be used when the interviews are typed up. 
Yes, I give my permission for the interview to be tape recorded    
No, I do not give my permission for the interview to be tape recorded  
Interviewee’s signature:  Date:  
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APPENDIX C: INTERVIEW GUIDE FOR FACTORS AFFECTING 
ACCEPTABILITY OF IPT AMONG HEALTH CARE PROVIDERS IN SELECTED 
HIV CLINICS IN NAIROBI COUNTY. 
 
PART A: General information: 
 
Please tick (  ) on an appropriate answer of your choice or fill the blanks accordingly 
Health facility Information: 
1. Hospital Name:  _____________________ 
2. Level of health facility:___________________________ 
3. Constituency:________________________________ 
4. HIV/TB integrated services model: 
Partial integration (     ) 
Full integration (     ) 
 
Health Worker Demographic details: 
5. Sex: 
Male (      )                  Female (     ) 
 
6. Age:  ________ Years 
7.  Job Category: 
General practitioner/ doctor (    ) 
Clinical officer (    ) 
Nurse (     ) 
Community health worker (     ) 
HIV counsellor (     ) 
Other (specify)___________________________ 
 
 
8. Years of experience in the HIV/TB department:  
(a) Less than 1 year 
(b) 2 - 4 years 
(c) More than 4 years 
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Part B: 
 
Briefly introduce yourself in terms of your background and your work in the clinic. 
 
1. (a) What do you think about IPT as an intervention for TB prevention in PLHIV? 
(b) May I know about your satisfaction and comfort with the intervention? 
(c) What factors make you feel that way about the intervention? 
 
2. How does the environment of the HIV clinic affect your delivery of IPT to your 
patients? (probe on the environment within the clinic/ health facility and the 
environment outside the heath facility i.e. community) 
 
3. How does the management affect your delivery of IPT to PLHIV at the facility? 
(Probe on the management of the clinic, management of the entire health facility, 
County/ district management of health services) 
 
4. (a) How would you describe your colleagues’ perception of IPT delivery to PLHIV? 
(b) How does their perception affect your perception and delivery of IPT for PLHIV? 
 
5. How do you think personal level factors affect your delivery of IPT to PLHIV at the 
facility?  (Probe on level of experience, training and any other factors that the 
participants may think about or mention) 
 
6. (a) Could you please describe your patients’ response to IPT? 
(b) Are there any patient level factors affect your delivery of IPT to other patients? 
How do they affect your perception of the intervention? 
 
7. If you had a chance, is there anything you would have liked to change regarding IPT 
administration at your clinic? 
 
8. To sum it up, what is your overall perception of IPT? 
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APPENDIX D: INFORMATION SHEET AND INFORMED CONSENT FORM FOR 
QUESTIONNAIRE SURVEY 
School of Public Health 
University of the Witwatersrand, Johannesburg 
Information Sheet for Questionnaire 
Good day.  
Introduction: 
My name is Elvis Omondi Achach Wambiya and I am an MSc Epidemiology 
(Implementation Science) student at the School of public Health, University of the 
Witwatersrand, Johannesburg, South Africa.   
Purpose of the study and methods: 
I am conducting a study to assess the acceptability of IPT (Isoniazid Preventive Therapy) 
among health care providers in selected HIV clinics in Nairobi County, Kenya. This research 
is a partial fulfilment of the requirements for the degree of MSc Epidemiology 
(Implementation Science) from the University of the Witwatersrand, Johannesburg, South 
Africa.  The study utilizes a mixed methods approach and therefore will involve in-depth 
interviews as well as filling in a questionnaire survey. Surveys will be conducted after 
analysis of in-depth interviews. 
Invitation to participate: 
As a health care provider in one of the select facilities, you have been selected to participate 
because we believe that you will be able to provide us with valuable information about IPT. 
We would like to invite you to participate in this study and to request your permission to 
conduct this survey. 
I would like to know your thoughts and perceptions about the intervention, as well as factors 
you think affect the way you feel about the intervention.  
Benefits and Risks: 
Though the study has no direct benefit to you, your views will help to highlight the quality of 
TB care that is offered to PLHIV at your clinic. This will not only be useful to health care 
providers and facility administrators but also to policy makers to improve IPT administration.  
There is no anticipated risk of harm from participating in the study. However, if you 
experience any distress following participation, you are encouraged to inform the researcher 
or contact the resources provided at the end of this information sheet. 
Confidentiality and anonymity: 
All information you provide will be kept confidential. The questionnaire that you fill will be 
made anonymous and your name will not be attached to it. Instead, the questionnaire will 
have a research code attached to it which only the researcher will know about. The electronic 
version of your survey responses will be stored in a password protected computer and the 
files encrypted to ensure that no one else has access to your given information. Hard copies 
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of questionnaires will be kept securely in a locked cabinet for ten years. At the end of this 
period, they will be destroyed. 
Voluntariness: 
Participation in the survey is voluntary and you are free to withdraw your participation at any 
time during the session without any recourse. There will be no negative consequences if you 
do not want to be interviewed. You will be asked to sign a consent form to show that you 
voluntarily agreed to take part. 
Reimbursement: 
Please note that there will be no reimbursement for taking part in responding to the survey.  
Duration: 
The survey will take about half an hour to complete and will be in English language. 
Data collected will be compiled in a thesis report, and may be shared in publications or 
presentations.  
Contacts: 
If you have any concerns or questions regarding any aspect of this study, please contact me or 
my supervisors on: 
Elvis Omondi Achach Wambiya 
Tel No. +254797184545 
Email: eowambiya@gmail.com 
 
Dr. Latifat Ibisomi (Supervisor) 
Senior Lecturer and Course Coordinator, 
School of Public health, 
The University of the Witwatersrand. 
Email: Latifat.Ibisomi@wits.ac.za 
 
Dr. Martin Atela (Supervisor) 
Knowledge Translation Scientist - AFIDEP (African Institute of Development and 
Policy), 
Lecturer – School of public Health, University of Nairobi, 
Nairobi, 
Kenya. 
Email: martin.atela@afidep.org 
In case of any complaint or other concerns about any aspect of this study, please get in touch 
with the Ethics Committee on the following contacts: 
Chairperson: peter.cleaton-jones1@wits.ac.za  
Administrators - Ms Zanele Ndlovu/ Mr Rhulani Mkansi/ Mr Lebo Moeng  
Tel: 011 717 2700/2656/1234/1252  
Email: HREC-Medical.ResearchOffice@wits.ac.za 
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INFORMED CONSENT FORM  
I consent and volunteer to participate in a study to assess the acceptability of Isoniazid 
Preventive Therapy among health care providers in selected HIV clinics in Nairobi County, 
Kenya.. The study is being conducted by Mr. Elvis Omondi Achach Wambiya; a Master’s 
student from University of the Witwatersrand, Johannesburg, South Africa.  
I confirm that: 
1. I was provided with an information sheet that explained what the study is about I have 
read and understood the information about the study as provided in the information 
sheet.  
2. I have been given the opportunity to ask questions about the project and my 
participation.  
3. I understand that I will not benefit directly from participating in the study.  
4. I understand that I can withdraw at any time without giving reasons and there are will 
be no risks or penalty for withdrawing. 
5. It has been clearly explained to me that the research is confidential and anonymous. 
i.e. and what I say will not be linked to me as a person and that the information will 
only be used for this research purpose and not shared with other people that are not 
part of this research team.  
6. It has been clearly explained to me that information from this research may be used in 
a thesis report, publications or presentations.  
 
Participant  
Signature:  ___________________      Date:  _______________________ 
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APPENDIX E: QUESTIONNAIRE FOR ACCEPTABILITY OF IPT AMONG 
HEALTH CARE PROVIDERS 
Code: …………………. 
Date: …………………... 
A. Please give the health facility details below by ticking [   ] against your selected 
response. 
FACILITY DETAILS 
Hospital Name Kenyatta National Hospital [         ]                            
Mama Lucy Kibaki Hospital [        ] 
Mbagathi District Hospital [        ] 
 
Level of health facility National referral [         ]                            
County referral [        ] 
County Hospital [        ] 
Sub -County Hospital [        ] 
 
HIV/TB integrated services 
model 
 
Partial integration [       ] 
Full integration [       ] 
 
Please provide your demographic details below by ticking [   ] against your selected 
response or filling the blanks accordingly. 
PARTICIPANT DEMOGRAPHIC DETAILS 
First Name  
Last Name  
Gender Male [         ]                            Female [        ] 
 
Age in Years  
 
Job Category Medical officer [       ] 
Clinical officer [       ] 
Nurse [       ] 
Pharmacist [       ] 
Counsellor  [       ] 
Other ___________________ 
Years of Experience  Less than 2 years  [       ] 
2 – 4 years  [       ] 
More than 4 years  [       ] 
 
B. Kindly respond to the following short questions regarding IPT by ticking [   ] on 
the circle that best represents your response. 
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COMFORT/ SATISFACTION WITH THE INTERVENTION 
I always provide IPT (front line 
providers) / IPT must always be 
provided (other cadres) to people 
living with HIV who meet the 
eligibility criteria 
 
IPT is a very effective intervention 
in preventing TB in people living 
with HIV 
 
I have no queries or doubts about 
IPT 
 
If I was an eligible patient, I would 
comfortably take the required IPT 
regimen  
 
I am comfortable with the 
guidelines set for IPT delivery to 
people living with HIV 
 
The guidelines set for IPT need 
some revision 
 
I am concerned about adverse 
effects and/ or deaths related to 
IPT among the patients 
 
I am comfortable with the 
duration of IPT treatment (6 
months) to our patients 
 
Patients can still get TB while on 
IPT treatment 
 
 
 
 
C. Kindly respond to the following short questions regarding IPT by ticking [   ] on 
the circle that best represents your response. 
FACTORS AFFECTING IPT ADMINISTRATION 
Question SURVEY SCALE 
1. Policy makers consulted with the 
health care providers in the clinic 
before introduction of the IPT 
program in the clinic 
 
2. Policy makers consulted with the 
health care providers in the clinic 
before revision of the IPT program 
in the clinic 
 
3. There is pressure from policy 
makers to deliver IPT to patients 
 
 
73 
 
4. IPT may develop resistance to 
TB- related drugs among the 
patients 
 
 
5.  I am very confident about the 
effectiveness of IPT in preventing 
TB among the patients 
 
6.  More research is required on 
the effectiveness of IPT 
 
7. The procedure for eligibility 
before IPT delivery takes a long 
time 
 
 
8. I need more training and 
information about IPT 
 
9. I require more evidence/ 
information on the effectiveness of 
IPT in preventing TB among the 
patients  
10. I require more evidence/ 
information on adverse effects 
and/ or deaths related to IPT 
among the patients  
11. My colleagues are positive 
about IPT  
 
 
12. Patients in our clinic adhere to 
IPT medication 
 
 
 13. IPT increases pill burden to our  
patients 
 
14. Patients require more 
information about IPT 
 
15. The clinical state of the patient 
immunologically and virologically is 
important before IPT initiation 
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16. The drug regimen of the 
patients (ARVs and others) is 
important before IPT initiation 
 
17. Patients develop severe side-
effects while on IPT treatment 
 
 
18. Patients refuse to take IPT 
medication 
 
19. IPT related services (screening, 
drug delivery, support) are well 
integrated in our clinic 
 
20. The working environment in 
the clinic is very comfortable  
 
21. There is a high workload for 
health care providers in the clinic 
as far as IPT is concerned 
 
 
22. We experience isoniazid (INH) 
stock-outs sometimes in the clinic 
 
 
23. The supply chain of Isoniazid 
and other IPT related supplies is 
effective 
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APPENDIX F: IMPLEMENTATION LITERATURE 
A number implementation research studies have highlighted the importance of quality and 
effective implementation of health care interventions and are continually stressing the 
importance of assessing the implementation of health interventions to ensure desired health 
outcomes (22-24, 56). Effective evidence-based interventions often fail to produce their 
desired outcomes due to the ‘implementation gap’ that exists between knowledge or evidence 
and practice (16, 17, 19, 72). There is therefore a need for bridging that gap to ensure that 
evidence-based programs in health care produce their desired outcomes (16, 18, 19, 67).  
Implementation researchers have developed different theories, frameworks and models to 
understand, guide and assess the implementation of interventions. This has been inspired by 
the need to effectively bridge the research to practice gap (73). Wandersman et al. 2008 
developed the interactive systems framework (ISF) to guide effective implementation by 
describing the systems and processes involved in moving from research and testing to 
widespread implementation (18). It highlights three systems required to carry out functions 
necessary for dissemination and implementation, namely: synthesis and translation system, 
support system and delivery system. Meyers et al. 2012 enhanced the ISF’s emphasis on 
implementation by developing the Quality Implementation Framework (QIF) through a 
synthesis of previous literature on 25 different implementation frameworks (74). The QIF 
presents critical steps in the implementation process along with specific activities to be 
followed to achieve quality implementation (74).   
Frameworks and models have also been developed for factors hypothesized to influence 
implementation of interventions. Durlak and Dupre (2008) developed the ecological 
framework for understanding effective implementation where they hypothesized that 
implementation is influenced by five categories of variables: innovations, providers, 
communities, the prevention delivery system (i.e., features related to organizational capacity) 
and the prevention support system (i.e., training and technical assistance), the latter two 
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factors connected to the ISF (56). Some of the factors identified by Durlak and Dupre (2008) 
were consistent with literature from other researchers (73). Damschroder et al (2009) 
reviewed existing implementation theories and frameworks to identify common constructs 
that affect successful implementation across a wide variety of settings. Their resulting 
typology, Consolidated Framework for implementation Research (CFIR), largely overlaps 
with Durlak and Dupre’s (2008) analysis where they concluded that structural, 
organizational, provider and innovation-level factors predicted implementation outcomes 
(57). Chaudoir et al. (2013) went ahead to evaluate measures available to assess constructs 
within five factors hypothesized to predict implementation outcomes, namely: structural-, 
organizational-, patient-, provider- and innovation-level (58). Structural, patient and 
innovation factors were less frequently assessed by the measures (58). 
Context plays a central role in implementation research and its importance when conducting 
implementation research has been highly emphasized by different authors (15, 23, 24, 75). 
Contexts in which implementation efforts occur are complex and involve multiple interacting 
levels (e.g., providers, patients, teams, service units) with wide variation across settings (24). 
This must be taken into account while conducting the research. An evidence-based practice 
(EBP) may fail to be adopted or may be adapted with compromised fidelity due to contextual 
pressures (24). Therefore implementation research requires clear, consistent and collective 
use of theory to build knowledge about what works, where it works and why it does (76). 
A wide range of qualitative and quantitative methods can be used in implementation research. 
Most implementation evaluation processes involve mixed qualitative and quantitative 
measures and have been highly recommended in implementation research (15). Research 
methods specifically developed to answer implementation research questions include: 
pragmatic trials, effectiveness-implementation hybrid trials, quality improvement studies, 
participatory action research and mixed methods research (15).  
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APPENDIX H: ETHICS CLEARANCE LETTER FROM KNH-ERC, KENYA 
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